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Recent studies in our laboratory demonstrated that in chronologically aging yeast grown under 
CR conditions LCA, a natural anti-aging compound, alters the age-related dynamics of changes 
in mitochondrial abundance and morphology, respiration, membrane potential, and ROS 
production. Cardiolipin (CL), a dimeric glycerophospholipid that is synthesized and almost 
exclusively localized in the inner mitochondrial membrane, has been shown to modulate 
mitochondria-governed processes whose dysfunction underlies aging and age-related 
pathologies. Phosphatidylethanolamine (PE) is another glycerophospholipid that is almost 
exclusively synthesized in the inner mitochondrial membrane, from which it is then distributed to 
various other cellular membranes. Hence, it is likely that the synthesis and stability of CL and, 
perhaps, PE in the inner mitochondrial membrane are important targets of longevity-extending 
and health-improving interventions. Because of the plausible importance of mitochondrially 
synthesized CL and PE in the longevity-extending effect of LCA, other graduate students in our 
laboratory elucidated how mutations eliminating nucleus-encoded mitochondrial proteins 
involved in the synthesis of CL and PE within the inner mitochondrial membrane influence the 
lifespan-extending efficacy of LCA in chronologically aging yeast grown under CR conditions. 
The results of this genetic analysis suggested that the synthesis of both these membrane lipids in 
mitochondria plays an essential role in the ability of LCA to extend longevity of yeast placed on 
iii 
a CR diet. All these findings prompted us to elucidate how LCA influences the composition of 
mitochondrial membrane lipids in chronologically aging yeast grown under CR conditions. To 
attain this objective, in experiments described in my thesis we used mass spectrometry (MS)- 
based lipidomics to elucidate the effect of LCA on the repertoire and quantities of membrane 
lipids in mitochondria that were purified from wild-type (WT) strain and from various long- and 
short-lived mutant strains impaired in different aspects of CL and PE metabolism. By correlating 
the effects of LCA on the age-related dynamics of changes in the composition and quantities of 
membrane lipids in mitochondria of these strains to the effects of this anti-aging compound on 
their chronological lifespan, we concluded that under CR conditions LCA extends yeast 
longevity by remodeling the composition of mitochondrial membrane lipids and thereby 
modulating longevity-defining processes confined to and governed by mitochondria. 
Specifically, findings described in my thesis strongly suggest that LCA extends longevity of WT 
yeast by (1) elevating the level of phosphatidylserine (PS; a precursor for the synthesis of PE in 
mitochondria) in the mitochondrial membrane, thereby enhancing its positive effect on 
longevity-defining processes in this membrane; (2) reducing the level of PE in the mitochondrial 
membrane, thereby weakening its negative effect on longevity-defining processes in this 
membrane; and (3) proportionally decreasing the levels of PE and CL in the mitochondrial 
membrane, thereby increasing PS/CL and PS/PE ratios but maintaining PE/CL ratio of 
mitochondrial membrane lipids and causing some longevity-extending changes in this 
membrane. It is important to emphasize that these LCA-induced alterations in mitochondrial 
membrane lipids can satisfactorily explain the observed implications of LCA treatment on 
mitochondrial structure and function, including (1) the ability of LCA to cause dramatic changes 
in the length and curvature of the inner mitochondrial membrane; and (2) the ability of LCA to 
 
activate protein machines involved in mitochondrial respiration, the maintenance of 
 
iv 
mitochondrial membrane potential, ROS production in mitochondria and mitochondrial fusion. 
 
Based on our recent findings and data of other researchers working in the field of 
mitochondrial biology, we hypothesized that, by altering the level of CL and other 
glycerophospholipids within the mitochondrial membrane, LCA could modulate the 
stoichiometry, composition and/or functional state of respiratory supercomplexes (respirasomes) 
in the inner mitochondrial membrane. To test the validity of this hypothesis, in studies described 
in my thesis we used a multistep method for recovery of intact respiratory complexes and 
supercomplexes from purified yeast mitochondria, their subsequent first-dimension 
electrophoretic separation using so-called blue-native gel electrophoresis (BN-PAGE), their 
resolution into individual protein components with the help of denaturing Tricine-SDS-PAGE, 
and the mass spectrometry (MS)-based identification of each of these individual protein 
components. Findings described in my thesis validate our hypothesis. Specifically, these findings 
revealed several ways of rearranging respiratory supercomplexes in the inner mitochondrial 
membrane of cells exhibiting altered mitochondrial membrane lipidome in response to LCA 
treatment or genetic manipulations impairing the synthesis of CL and other glycerophospholipids 
within the inner membrane of mitochondria. First, by altering the level of CL and other 
glycerophospholipids synthesized and residing in the inner mitochondrial membrane, LCA 
modulates the abundance of several major respiratory supercomplexes (respirasomes) in this 
membrane. Second, LCA- and genetic manipulations-driven changes in the inner mitochondrial 
membrane lipidome cause a recruitment of a number of new mitochondrial protein components, 
not previously known for being permanently associated with the ETC, into the remodeled 
respirasomes. Importantly, many of the proteins newly recruited into the remodeled respirasomes 
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1.1 Programmed complexity of a multistep process of biological aging 
 
Aging of multicellular and unicellular eukaryotic organisms is a complex biological 
process that affects numerous cellular activities [1 - 16]. At the organismal level, aging 
manifests itself as a progressive decline in the ability of an organism to resist stress, 
repair damage and battle disease [2, 3, 9, 10, 13 - 15]. At the demographic level, aging 
can be defined as an exponential increase in the mortality rate with the age of the cohort 
[2, 3, 5, 12 - 14]. 
Two contradictory views of biological aging exist. One view foresees that aging of 
multicellular and unicellular eukaryotic organisms is due to a “passive” lifelong build-up 
of unrepaired damage to cellular macromolecules and organelles [3, 12 - 14, 17]. By 
impairing normal functioning of the entire organism, progressive, age-related 
accumulation of such damage increases a risk of disease and death [11 - 15]. Hence, in 
this view of biological aging, it is simply a result of the time-dependent, unavoidable 
accumulation of unrepaired cellular and molecular damage [3, 12, 17]. Yet, recent 
evidence strongly suggests that aging is the final step of a developmental program. 
According to this alternative view, aging is an “active” route, in which a limited number 
of evolutionarily conserved nutrient- and energy-sensing signaling pathways (often called 
“master regulators”) orchestrate numerous cellular processes; each of these cellular 
processes is considered as a functional module integrated with other modules into a 
biomolecular network [18 - 22]. In this view of aging as an “active” route, a synergistic 







longevity by establishing the rate of cellular and organismal aging; furthermore, the 
relative impact of each module on the rate of aging in a particular organism or cell type 
could differ at various stages of its lifetime and could also vary in different organisms 
and cell types [19 - 25]. The recently intensified reconstruction of various biomolecular 
networks of longevity and aging on the cellular and organismal levels is based on the 
application of a network biology approach, which has been initially devised and 
implemented by Witten for theoretical modeling of the replicative senescence process in 
mammalian organisms [26 - 28]. The use of system biological and computational 
analyses of protein-protein interactions, age-related changes in gene expression and/or 
longevity-defining metabolic alterations has resulted in numerous models of such 
longevity and aging networks [18, 25, 29 - 43]. 
The conducted by our laboratory analysis of the metabolic history of 
chronologically aging yeast provided evidence that their longevity is programmed by the 
level of metabolic capacity and organelle organization that yeast developed, in a diet- 
specific fashion, before entering a quiescent state - and, thus, that chronological aging in 
yeast is likely to be the final step of a developmental program progressing through at 
least one checkpoint prior to entry into quiescence [12]. Moreover, our recent 
investigation of how lithocholic acid (LCA) - a synthesized and secreted by mammals 
bile acid whose potent anti-aging ability we discovered [44] - influences longevity and 
several longevity-defining cellular processes in chronologically aging yeast if added to 
growth medium at different periods of lifespan has revealed that LCA can extend 
longevity only if added at either of two lifespan periods [45]. One of these critical 







period exists in early stationary phase [45]. Our findings suggested a mechanism linking 
the ability of LCA to increase the lifespan of CR yeast only if added at either of the two 
periods to its differential effects on various longevity-defining processes [45]. In this 
mechanism, LCA controls these processes at three checkpoints that exist in 
logarithmic/diauxic, post-diauxic and early stationary phases. We therefore proposed a 
hypothesis in which a biomolecular longevity network in chronologically aging yeast 
progresses through a series of checkpoints; at each of these checkpoints (1) genetic, 
dietary and pharmacological anti-aging interventions modulate a distinct set of longevity- 
defining processes (modules) comprising the network; and (2) checkpoint-specific master 
regulators monitor and govern the functional states of these processes (modules) in order 
to limit the age-related accumulation of molecular and cellular damage [45]. In our 
hypothesis, the resulting changes in the dynamics of individual processes (modules) 
constituting the network and in its general configuration are critically important for 
defining longevity by establishing the rate of cellular and organismal aging [45]. 
Recent findings support the validity of our hypothesis on a stepwise progression of 
a biomolecular longevity network through a series of checkpoints. In fact, 
studies in chronologically aging yeast revealed that, by promoting coupled respiration in 
mitochondria, elevating the mitochondrial membrane potential and increasing 
mitochondrial reactive oxygen species (ROS) production during logarithmic growth 
phase, a CR diet and some pharmacological interventions extend longevity by causing 
changes in several longevity-defining processes during the subsequent diauxic, post- 
diauxic and stationary phases. These changes include (1) increased intracellular levels of 







metabolism in the endoplasmic reticulum, lipid bodies and peroxisomes; (3) reduced cell 
susceptibility to age-related forms of mitochondria-controlled apoptotic and lipid-induced 
necrotic death; (4) an attenuation of mitochondrial fragmentation; (5) a reduction in the 
mitochondrial membrane potential and mitochondrial ROS production; (6) elevated 
stability of nuclear and mitochondrial genomes; and (7) enhanced resistance to chronic 
oxidative and thermal stresses [12, 44, 46 - 49]. It seems that in chronologically aging 
yeast TORC1 (the target of rapamycin protein complex 1) operates as one of the 
predicted by our hypothesis checkpoint-specific master regulators that at a checkpoint in 
logarithmic growth phase can monitor and govern a functional state of mitochondria [46 - 
49]. 
 
Furthermore, recent studies in chronologically aging yeast suggest the existence of 
two checkpoints at which the intracellular level of trehalose defines longevity by 
modulating cellular proteostasis throughout lifespan [12, 50]. At one of these lifespan 
checkpoints in post-diauxic phase, trehalose operates as an anti-aging compound that (1) 
stabilizes the native state of proteins and thereby reduces the formation of their aberrantly 
folded species; (2) reduces the formation of insoluble protein aggregates by shielding the 
contiguous exposed hydrophobic side chains of amino acids that are abundant in 
misfolded, partially folded and unfolded protein species and promote their aggregation; 
and (3) protects cellular proteins from oxidative carbonylation by interacting with their 
carbonylation-prone misfolded and unfolded species [50]. At another lifespan checkpoint 
in stationary phase, trehalose functions as a pro-aging compound that shields the 
contiguous exposed hydrophobic side chains of amino acids abundant in misfolded, 







for binding with these patches of hydrophobic amino acid residues, trehalose interferes 
with the essential longevity-extending process of chaperone-assisted refolding of 
aberrantly folded protein species [50]. 
Moreover, a confirmation of our hypothesis on a stepwise progression of a 
biomolecular longevity network through a series of checkpoints, each being monitored by 
a limited set of checkpoint-specific master regulators, comes from studies that revealed 
distinctive timing requirements for modulating the pace of organismal aging in the 
nematode Caenorhabditis elegans. This roundworm devotes at least three independent 
regulatory systems that, by monitoring a particular cellular process or processes during a 
specific stage of life, use this information to establish the rate of cellular and organismal 
aging. The first of these three regulatory systems influences lifespan by operating only 
during larval development [51 - 53]. By monitoring mitochondrial respiration, 
electrochemical membrane potential and ATP production early in life, during the L3/L4 
larval stage, it establishes the rate of aging that persists during adulthood [51 - 54]. 
Mechanisms underlying the essential role of this first regulatory system in defining 
longevity of C. elegans may involve (1) a remodeling of mitochondria-confined ATP 
production pathways during larval development, which may establish a specific 
configuration of the longevity-defining metabolic network in a cell-autonomous manner 
[55, 56]; and (2) a retrograde signalling pathway that in response to mild mitochondrial 
impairment and stress during the L3/L4 larval stage activates UBL-5 (ubiquitin-like 
protein 5)/DVE-1 (defective proventriculus protein 1)-driven expression of the 
mitochondria-specific unfolded protein response (UPR
mt
) genes in the nucleus, thereby 
 
stimulating synthesis of a subset of UPR
mt  







cell-autonomously but also in a cell-non-autonomous fashion [57, 58]. The second 
regulatory system operates exclusively during adulthood, mainly during early adulthood, 
to influence the lifespan of C. elegans via the insulin/IGF-1 (insulin-like growth factor 1) 
longevity signaling pathway and the transcription factor DAF-16 (dauer formation 
protein 16) [59 - 61]. Of note, the magnitude of the effect of this second regulatory 
system on lifespan declines with age, becoming insignificant after several days of 
adulthood [59]. The third regulatory system influences the lifespan of C. elegans in a 
diet-restriction-specific fashion by operating exclusively during adulthood [62]. This 
system regulates longevity via the transcription factor PHA-4 (pharynx development 
protein 4) only in response to reduced food intake. Importantly, the PHA-4-mediated 
regulatory system operates independently of the other two regulatory systems modulating 
the rate of aging in C. elegans [62]. In our hypothesis for a stepwise development of a 
longevity network configuration at a series of checkpoints, a genetic, dietary or 
pharmacological anti-aging intervention may modulate the key cellular process or 
processes that are monitored at a particular checkpoint by a master regulator of the 
longevity control system. In C. elegans, UBL-5/DVE-1, DAF-16 and PHA-4 may 
function as the checkpoint-specific master regulators of longevity by governing 
progression through the three consecutive checkpoints operating during larval 
development and early adulthood [57, 59 - 62]. 
In addition, our hypothesis on a stepwise progression of a biomolecular longevity 
network through a series of checkpoints, each being monitored by a limited set of 
checkpoint-specific master regulators, could be applicable to laboratory mice and rats. 







implemented at the age at which skeletal development is complete, the maximal benefit of 
this low-calorie diet for longevity can be achieved only if CR is initiated during the rapid 
growth period [63 - 65]. These findings suggest that laboratory mice and rats (1) could 
employ a CR-dependent longevity control system that, by monitoring some key, 
longevity-defining cellular processes, can establish a particular rate of cellular and 
organismal aging; and (2) could have at least two checkpoints, one in early adulthood and 
another in late adulthood, at which the proposed CR-dependent longevity control system 
senses the rate and/or efficiency of the critical cellular processes that define longevity. It 
is likely therefore that the proposed CR-dependent longevity control system in laboratory 
mice and rats can extend longevity even if the rate and efficiency of the critical, CR- 
modulated cellular processes are appropriate only at the late-adulthood checkpoint, but 
not as markedly as if they are suitable already at the checkpoint in early adulthood. 
Taken together, these findings support the validity of our hypothesis that aging in 
organisms across phyla is the final step of a developmental program whose progression 
through several lifespan checkpoints in a genotype-specific fashion is modulated by 
environmental cues (such as caloric and dietary intake, environmental stresses, endocrine 
factors, etc.) and is both monitored and governed by an evolutionarily conserved set of 
checkpoint-specific master regulators. Noteworthy, some theoretical considerations in 
support of the validity of our hypothesis on programmed aging progressing through 
several lifespan checkpoints have been also discussed in recent years [66 - 75]. 
The major challenge now is to get a greater insight into mechanisms that in 
chronologically aging yeast underly (1) a stepwise progression of the biomolecular 







defining processes comprising the longevity network by genetic, dietary and 
pharmacological anti-aging interventions administered at different checkpoints; and (3) a 
monitoring of these longevity-defining processes at each checkpoint by specific master 
regulators. To address this challenge, several important questions need to be answered. 
How will genetic, dietary and pharmacological anti-aging interventions known to directly 
target specific longevity-extending or longevity-shortening processes alter the age-related 
dynamics of changes in the proteomes, lipidomes and metabolomes of chronologically 
aging yeast? How will these interventions affect the chronology of other longevity- 
defining processes that comprise the longevity network but are known not to be directly 
modulated by these interventions? How will genetic and pharmacological anti-aging 
interventions that specifically modulate the functional states of several currently known 
master regulators of yeast longevity influence a timeline of changes in the proteomes, 
lipidomes and metabolomes of chronologically aging yeast and what will be their effects 
on the age-related dynamics of various longevity-defining processes comprising the 
longevity network? We shall have to answer these important questions if we want to 
understand the complexity of the biomolecular network whose progression through a 
series of checkpoints is modulated by various environmental cues and is governed by 




1.2 The budding yeast Saccharomyces cerevisiae is a beneficial model organism for 
understanding mechanisms of cellular aging in multicellular eukaryotes 
The baker’s yeast Saccharomyces cerevisiae, a unicellular eukaryotic organism with 
 







chemical biological and system biological analyses [76 - 79]. This yeast embodies a 
beneficial model for studying the basic biology of aging and understanding longevity 
regulation mechanisms in multicellular eukaryotes [4, 9, 18, 80 - 85]. 
There are two different ways to measure aging in yeast. Yeast replicative aging is 
monitored by counting the maximum number of daughter cells that a mother cell can 
produce before reaching a quiescent/senescent state; replicative aging in yeast is known 
to mimic aging of dividing, “mitotic” cells in a multicellular eukaryotic organism [4, 18, 
81, 85]. In studies presented in this thesis, we elucidated mechanisms underlying yeast 
chronological aging. This kind of aging is measured by the length of time during which a 
yeast cell remains viable following entry into a quiescent/senescent state [4, 18, 81, 85, 
86]. Chronological aging in yeast is known as an advantageous model for studying aging 
of non-dividing, “post-mitotic” cells (such as neurons) in a multicellular eukaryotic 
organism [4, 18, 81, 85, 86]. To monitor the progress of yeast chronological aging, a 
simple clonogenic assay measures the percentage of yeast cells that remain viable at 
different time points following entry into a quiescent/senescent state upon reaching the 
non-proliferative stationary phase [4, 12, 18, 81, 85, 86]. Both replicative and 
chronological aging of yeast can be significantly delayed by caloric restriction (CR), a 
low-calorie dietary regimen that extends lifespan in various multicellular eukaryotic 
organisms and delays the onset or reduces the incidence of many age-related diseases in 
mice and primates [9, 12, 18, 85 - 93]. 
Because longevity signaling pathways and mechanisms of their modulation by 
genetic, dietary and pharmacological interventions have been conserved during the 







yeast - in combination with the amenability of this unicellular eukaryote with annotated 
genome to comprehensive biochemical, genetic, cell biological, chemical biological and 
system biological analyses - enabled to (1) identify numerous novel longevity genes, all 
of which have been later implicated in regulating longevity of multicellular eukaryotic 
organisms; (2) establish the chemical nature of molecular damage that causes aging and 
accelerates the onset of age-related diseases across phyla; and (3) reveal several 
longevity-extending small molecules, all of which have been later shown to slow down 
aging, improve health, attenuate age-related pathologies and delay the onset of age- 




1.3 Some dietary and pharmacological interventions can extend longevity and 
improve health by attenuating age-related pathologies and delaying the onset 
of age-related diseases 
Nutrient intake is known to play an important role in defining longevity and improving 
health [96 - 99]. The dietary regimens known as caloric restriction (CR) and dietary 
restriction (DR) have been shown not only to extend longevity of evolutionarily distant 
organisms ranging from yeast to rhesus monkeys, but also to improve health by 
attenuating age-related pathologies and delaying the onset of age-related diseases across 
phyla [97 - 104]. A CR dietary regimen has been designed to reduce only calorie intake 
without compromising the supply of amino acids, vitamins and other nutrients [98 - 101]. 
In contrast, various DR diets have been developed to reduce the intake of nutrients (but 








In organisms across phyla, the beneficial effects of CR and DR diets on longevity 
and health are governed by a limited number of evolutionarily conserved signaling 
pathways. In a so-called “TOR-centric” view of longevity regulation, the AMPK/TOR 
(AMP-activated protein kinase/target of rapamycin) pathway is considered as the only 
signaling pathway underlying longevity-extending and health-improving effects of CR 
and DR [105 - 110]. In this “radical” view of longevity regulation, TORC1 - a core 
protein complex within the AMPK/TOR pathway - modulates the beneficial effects of 
CR and DR on longevity and health by performing the following three functions. First, 
TORC1 integrates the flow of information on the organismal and intracellular nutrient 
and energy status from AMPK (a protein kinase in the AMPK/TOR pathway), PKA (a 
protein kinase in the cAMP/PKA pathway), PKB/AKT (a protein kinase in the 
insulin/IGF-1 pathway), ERK1/2 (a protein kinase in the Raf/MEK/ERK signaling 
cascade) and P66
Shc 
(a mitochondria-confined sensor of the redox status within this 
 
organelle) [105 - 107]. Second, TORC1 operates in an AMPK-independent fashion as a 
sensor of the intracellular levels of amino acids [105 - 107]. Third, TORC1 functions in a 
sirtuin-independent manner as a control center that modulates a number of longevity- 
related processes by gathering and processing the information on the organismal and 
intracellular nutrient, energy and redox status and on amino acid availability [105 - 107]. 
The validity of the TOR-centric view on TORC1-governed modulation of the longevity- 
extending effects of CR and DR has been confirmed by studies in roundworms and 
replicatively aging yeast. Specifically, it has been demonstrated that various DR diets are 
unable to extend longevity of the nematode C. elegans under conditions that reduce TOR 







replicatively aging yeast can be eliminated through the impairment of any of the key 
components comprising the TOR signaling pathway [108]. 
Although in replicatively aging yeast the TOR pathway alone mediates the 
longevity benefit associated with CR, the lifespan-extending effect of this diet in 
chronologically aging yeast relies on a signaling network in which the protein kinase 
Rim15p functions as a nutritional integrator of the TOR and cAMP/PKA (cAMP/protein 
kinase A) signaling pathways; this network also includes some other signaling pathways 
that are not converged on Rim15p and remain to be identified [111]. Moreover, 
considering the comprehensive evidence for the convergence of the AMPK/TOR, 
cAMP/PKA and insulin/IGF-1 pathways in worms, fruit flies and mammals into a 
complex network regulating longevity [96, 112 - 115], it is believed that these three 
divergent and multiply branched signaling pathways equally contribute to the lifespan- 
extending effects of CR and DR in these organisms [112, 116 - 125]. Recent studies in 
the nematode C. elegans support the validity of the view in which a signaling network, 
rather than the AMPK/TOR pathway alone, mediates the longevity benefit associated 
with CR and DR by coordinating information flow along the convergent, divergent and 
multiply branched signaling pathways comprising this network [126]. 
Longevity in organisms across phyla can be extended, health improved, age-related 
pathologies attenuated and the onset of age-related diseases delayed not only by CR and 
DR diets. Certain chemical compounds, many of which are natural molecules synthesized 
and released into the environment by some organisms within an ecosystem, exhibit 
beneficial effects on longevity and health of other organisms comprising this ecosystem 







compounds target the AMPK/TOR signaling pathway that regulates longevity in 
evolutionarily distant organisms by responding to their intracellular nutrient and energy 
status. The type 2 diabetes therapeutic compound metformin has been shown to activate 
AMPK, thereby reducing TORC1 signaling and extending longevity in roundworms and 
mice [128, 129]. The glutamine synthetase inhibitor methionine sulfoximine is known to 
extend longevity of chronologically aging yeast by decreasing the intracellular 
concentration of the TORC1 activator glutamine, thereby reducing TORC1 signaling 
[130, 131]. By inhibiting upstream TORC1 activators PI3K and MEK, the compounds 
called LY294002 and U0126 (respectively) attenuate TORC1 signaling to increase the 
replicative lifespan of cultured human fibrosarcoma cells [132]. Furthermore, the 
macrocyclic lactone rapamycin acts through FKBP12 to inhibit TORC1, thereby 
extending (1) longevity in fruit flies and mice [133, 134]; (2) the replicative lifespans of 
cultured rodent fibroblasts, human epithelium cells and human fibrosarcoma cells [135]; 
and (3) the replicative and chronological lifespans of yeast [130, 136, 137]. Moreover, 
the xanthine alkaloid caffeine reduces the catalytic activity of Tor1p to extend longevity 
of chronologically aging yeast [138]. 
Several longevity-extending compounds delay aging by targeting the insulin/IGF-1 
signaling pathway, known to monitor the nutritional status of the whole organism. First, 
the serotonin receptor antagonist mianserin extends longevity of roundworms by 
modulating an upstream step in this pathway, thereby inhibiting neurotransmission 
related to food sensing and mimicking a DR-like physiological state [139]. Second, 
valproic acid targets a downstream step in the insulin/IGF-1 signaling pathway to 







FoxO transcriptional factor DAF-16 into the nucleus [140]. 
 
Some natural longevity-extending compounds delay aging, improve health and 
attenuate age-related pathologies by modulating longevity-defining processes controlled 
by proteins that currently are not considered as components of the AMPK/TOR, 
cAMP/PKA and insulin/IGF-1 signaling pathways but are known to be dynamically 
integrated into a longevity regulation network (see section 1.1) that they govern. 
Resveratrol is one of these natural anti-aging compounds. This small polyphenol 
produced by plants has been shown to modulate activities of numerous proteins by 
interacting with them [141, 142] and thereby inhibiting many longevity-shortening 
processes and activating a number of longevity-extending processes [143 - 149]. Due to 
its capability to modulate activities of numerous longevity-defining proteins and 
processes that these proteins govern, resveratrol exhibits a potent ability to (1) extend the 
replicative (but not chronological) lifespan of yeast [143]; (2) increase the replicative 
lifespan of cultured human fibroblasts [150]; and (3) extend longevity of roundworms, 
fruit flies, fishes and mice [144, 145, 151, 152]. Similar to resveratrol, sodium 
nitroprusside extends longevity by promoting sirtuin-dependent protein deacetylation. 
However, unlike resveratrol, sodium nitroprusside can activate expression of the gene 
encoding sirtuin SIRT1, thereby enhancing SIRT1-driven deacetylation of lysine 16 in 
histone H4 to establish an anti-aging pattern of transcription that ultimately leads to 
replicative lifespan extension in cultured human peripheral blood mononuclear cells 
(PMBC) [153]. A longevity-extending process of the reduction of histone acetylation can 
be promoted not only by sodium nitroprusside, but also by the natural polyamine called 







deacetylation, spermidine activates transcription of numerous autophagy-related genes, 
suppresses age-related necrotic cell death and ultimately extends the chronological 
lifespan of yeast, the replicative lifespan of cultured human PMBC, and longevity of 
roundworms and fruit flies [154, 155]. The process of histone modification is also a target 




has been shown to 
cause the age-related chromatin reorganization by altering transcription of genes involved 
in histone methylation, nucleosome composition and chromatin structure; these properties 
of Li
+  
are believed to underlie its beneficial properties as a mood stabilizer in humans and 
an anti-aging compound in roundworms [156]. 
Several anti-aging compounds extend longevity by influencing longevity-defining 
processes confined to or governed by mitochondria, cellular organelles known for their 
essential role in longevity regulation across phyla [113, 157 - 159]. One of these 
longevity-extending compounds is the plastoquinone derivate SkQ1. Following its sorting 
to mitochondria, SkQ1 functions as an antioxidant that attenuates oxidative damage to 
mitochondrial proteins and lipids, changes mitochondrial morphology, and impairs 
mitochondria-controlled forms of apoptotic and necrotic cell death known to be caused 
by an excessive accumulation of mitochondria-produced hydrogen peroxide [160]. By 
modulating these longevity-defining processes confined to mitochondria, SkQ1 not only 
extends longevity in fungi, daphnias, fruit flies and mice, but also improves health and 
delays the onset of age-related diseases in mice [160]. In roundworms and fruit flies, the 
detoxification of mitochondria-produced free radicals and the resulting enhancement of 
resistance to mitochondria-controlled oxidative stress underly longevity extension by 







It  is important to emphasize that all longevity-extending compounds known prior 
to our recent study [44] have been called “CR mimetics” and “DR mimetics” because 
they: (1) similar to CR and DR dietary regimens, increase lifespan and/or improve health 
under non-CR or non-DR conditions;  (2) unlike CR and DR diets, do not restrict caloric 
and nutrient intake; and (3) mimic longevity-extending and health-improving effects of 
CR and DR on metabolic pathways, physiological processes, stress response and gene 
expression [163 - 165]. Furthermore, almost all longevity-extending compounds known 
prior to our recent study [44] target the AMPK/TOR and insulin/IGF-1 pathways and 
impact the sirtuin-governed protein deacetylation module of the integrating these 
pathways longevity signaling network that defines longevity only in response to the 
organismal and intracellular nutrient and energy status. Moreover, such CR mimetics and 
DR mimetics as resveratrol, metformin and mianserin have been shown to increase 
lifespan and beneficially influence health only under non-CR or non-DR conditions, but 
do not extend longevity or improve health if the supply of calories or nutrients is limited 
[128, 139, 143, 144, 151]. We therefore introduced the term “adaptable” to define the 
AMPK/TOR, cAMP/PKA and insulin/IGF-1 signaling pathways and sirtuin-governed 
protein deacetylation module [44], all of which are integrated into the longevity 
regulation network targeted by the currently known longevity-extending CR mimetics 
and DR mimetics. By coining this term, we emphasized the fact that all these pathways 
and the sirtuin-governed module exhibit the beneficial effects on longevity and attenuate 
age-related pathologies only in response to certain changes in the extracellular and 
intracellular nutrient and energy status of an organism [44]. Of note, recent studies 
revealed that Li
+  







under DR conditions; however, the longevity-extending efficacies of both these chemical 
compounds under such nutrient-limited conditions has been shown to be significantly 
lower than that under non-DR conditions [133, 156]. Based on these observations, we 
proposed that some longevity assurance pathways could be “constitutive” or 
“housekeeping” by nature, assuming that they (1) modulate longevity irrespective of the 
extracellular and intracellular nutrient and energy status – in contrast to the adaptable 
AMPK/TOR, cAMP/PKA and insulin/IGF-1 signaling pathways and sirtuin-governed 
protein deacetylation module; and (2) do not overlap (or only partially overlap) with the 
adaptable pathways that are under the stringent control of calorie and nutrient availability 
[44]. To identify such housekeeping longevity pathway(s) operating in chronologically 
aging yeast, we carried out a chemical genetic screen for anti-aging small molecules that 
can extend longevity even under CR conditions [44]. We thought that, because under CR 
conditions the adaptable pro-aging pathways would be fully suppressed and the adaptable 
anti-aging pathways would be fully activated, a chemical compound that can further 
increase yeast chronological lifespan could target the housekeeping longevity pathway(s) 
that we were trying to identify. Our chemical genetic screen identified lithocholic acid 
(LCA), a bile acid, as one of these compounds. One of the major objectives of studies 
described in my thesis was to establish molecular and cellular mechanisms underlying the 
potent longevity-extending effect of LCA. Because our unpublished findings imply that 
LCA enters yeast cells and accumulates mainly in the inner mitochondrial membrane 
(Beach et al., manuscript in preparation), in studies described in my thesis we 
investigated how this bile acid influences mitochondrial membrane lipidome and how it 
 








1.4 Mechanisms underlying the essential role of lipid metabolism in longevity 
regulation 
It is well established that the deposition and mobilization of neutral lipids and the 
maintenance of their intracellular homeostasis in evolutionarily distant organisms play a 
pivotal role in longevity regulation [166 - 169]. However, the molecular and cellular 
mechanisms linking the metabolism of neutral lipids and longevity remain to be 
established. Recent studies carried out in our laboratory and findings by other researchers 
in the field suggest several of such mechanisms operating in chronologically aging yeast 
and multicellular eukaryotic organisms, as outlined in this section of my thesis. 
The two major species of neutral lipids in yeast cells are triacylglycerols (TAG) 
 
and ergosteryl esters (EE); they are known to be deposited in so-called lipid bodies (LBs) 
[170 - 172]. TAG and EE are the main storage molecules for free fatty acids (FFA), 
diacylglycerols (DAG) and ergosterol (ERG). Lipolysis of TAG produces FFA, which 
then can be incorporated into newly synthesized phospholipids and cardiolipins (CL) or, 
alternatively, degraded through β-oxidation within yeast peroxisomes [171, 172]. 
Lipolysis of TAG also generates various DAG species, which (1) serve as building blocks 
for synthesis of the phospholipids phosphatidylethanolamine (PE) and 
phosphatidylcholine (PC); and (2) act as potent signaling molecules modulating a protein 
kinase C (PKC)-dependent signal transduction network that governs multiple stress 
response-related and longevity-defining processes [173, 174]. Lipolysis of EE in yeast 
cells not only generates FFA but also leads to the formation of ERG, a sterol lipid known 







175, 176]. In sum, a fine-tuned modulation of the biosynthesis and degradation of the 
neutral lipids TAG and EE plays a pivotal role in regulating numerous processes in yeast 
cells, including (1) energy homeostasis; (2) phospholipid and cardiolipin biosynthesis; (3) 
neutralization of excessive amounts of membrane-perturbing species of FFA, ERG and 
TAG; (4) the FFA- and DAG-induced lipoapoptotic and necrotic modes of cell death; and 
(5) a DAG-modulated, PKC-dependent signal transduction network that governs multiple 
stress response- and longevity-related processes [170 - 176]. All these cellular processes 
are known for their essential roles in defining longevity of yeast and multicellular 
eukaryotic organisms [166 - 169, 173, 174, 177 - 179]. 
As in cells of higher eukaryotes, neutral lipids in yeast cells are synthesized in the 
endoplasmic reticulum (ER) [171, 172, 175, 180]. Lysophosphatidic acid (LPA) is the 
earliest precursor lipid molecule in the biosynthesis of TAG, a process that progresses 
through several acylation and dephosphorylation steps. The two alternative ways of 
synthesizing LPA include (1) acylation of glycerol-3-phosphate in a reaction catalyzed by 
either Gpt2p or Sct1p protein; and (2) acylation of dihydroxyacetone phosphate (DHAP), 
also in a Gpt2p- or Sct1p-dependent manner, followed by formation of DHAP from 1- 
acyl-DHAP in a reaction catalyzed by Ayr1p [171, 172, 175, 180]. Following a transfer 
of an acyl group to the sn-2 position of LPA and the resulting formation of phosphatidic 
acid (PA), PA is dephosphorylated by one of three dephosphorylases, Pah1p, Dpp1p or 
Lpp1p, to form DAG. An alternative way of synthesizing DAG consists in the removal of 
the head group-phosphate from a glycerophospholipid molecule [171, 172, 175, 180]. 
Acylation of the sn-3 position in a DAG molecule, either with acyl-CoA (in a reaction 







glycerophospholipid (in a reaction catalyzed by Lro1p), ultimately results in TAG 
formation. The synthesis of EE, another neutral lipid in yeast cells, is confined to the ER 
and involves the transfer of an acyl group from acyl-CoA to ERG in a reaction catalyzed 
by Are1p or Are2p [171, 172, 175, 180]. 
The degradation of TAG in yeast cells is confined to LBs, where this neutral lipid 
undergoes lipolysis catalyzed by the Tgl2p, Tgl3p, Tgl4p and Tgl5p lipases [171, 172, 
175, 180]. EE is degraded either within the plasma membrane in a Yeh2p-catalyzed 
reaction or within LBs in a reaction driven by the Tgl1p lipase [171, 172, 175, 180]. 
A body of evidence supports the view that the accumulation and lipolytic 
degradation of neutral lipids in LBs of fat storage tissues define longevity of multicellular 
eukaryotic organisms [181 - 183]. LBs have been found in most eukaryotic and some 
prokaryotic cells; to reflect differences in their origin, biochemical content, morphology 
and other features observed in different biological systems, LBs are also often called lipid 
droplets, lipid particles and oil bodies [184, 185]. 
Until recently, LBs have been considered as relatively inert organellar 
compartments whose only function is to store excess energy, FFA, phospholipids and 
sterols that are deposited mainly in the forms of TAG and steryl esters [184, 186 - 189]. 
In LBs, these neutral lipids form a dense core, which is surrounded by a monolayer of 
phospholipids and associated proteins.  The neutral lipid core of LBs can be hydrolyzed 
in a regulated fashion by several types of lipases, thereby enabling a retrieval of stored 
FFA, phospholipids and sterols that then can be used to (1) provide energy via fatty acid 
oxidation during times of nutrient scarcity; (2) maintain the homeostasis of membrane 







and outside of the cell [184 - 189]. 
 
Recent findings contradict a traditional view of LBs as relatively static organellar 
compartments that function only in the deposition of neutral lipids. A growing body of 
evidence implies that LBs constitute dynamic organellar compartments whose protein 
and lipid composition, de novo formation from the ER template, growth, fragmentation, 
shrinkage due to lipolysis, movement, and association with other organelles are regulated 
by numerous proteins and support essential processes within a cell [187, 189, 190 - 202]. 
Hence, the new paradigm is that LBs are dynamically integrated into vital cellular 
processes and can serve both as an intracellular signaling compartment and as an 
organizing platform orchestrating these processes. For example, studies in yeast revealed 
that the phosphorylation and activation of the LBs-associated lipase Tgl4p by cyclin- 
dependent kinase 1 is required for mobilization of LBs-deposited TAG, thereby providing 
fatty acids and phospholipids for the secretory vesicle-dependent bud formation that 
stimulates the G1/S phase transition to enable cell-cycle progression [203]. Furthermore, 
it has been demonstrated that LBs in white adipose tissue (WAT) of mice modulate the 
synthesis and secretion of adipokines and the lipokine C16:1n7-palmitoleate, thereby 
being integrated into a regulatory network that maintains metabolic homeostasis whose 
impairment is associated with obesity, insulin resistance, type 2 diabetes, atherosclerosis 
and inflammatory disorders [195, 197, 204 - 208]. Moreover, LBs have been shown to 
play important roles in the regulation of many vital processes within mammalian cells by 
recruiting proteins from other cellular locations, temporally housing them, managing their 
availability and modulating their activities [187, 197, 201]. Specifically, the recruitment 







removes excess proteins from other organellar compartments, inactivates these proteins 
and/or stores them for later use; (2) promotes the refolding of unfolded proteins targeted 
to LBs by recruiting molecular chaperones from the cytosol; (3) provides a surface for the 
ordered degradation of partially unfolded  and misfolded LBs-bound proteins that 
otherwise can form toxic aggregates in the cytosol; and (4) delivers some LBs-associated 
proteins to their target organellar compartments via permanent or transient contact sites 
[187, 197, 201, 209 - 211]. 
It should be emphasized that recent findings in evolutionarily distant organisms 
unveiled the essential roles for LBs in longevity regulation. For example, it has been 
shown that various interventions that inhibit the deposition of neutral lipids in LBs or 
activate their lipolytic degradation in fat storage tissues of the nematode C. elegans, the 
fruit fly Drosophila melanogaster or laboratory mice also extend their longevity [212 - 
217]. In C. elegans, certain humoral signals produced and secreted by somatic cells in the 
gonad stimulate nuclear import of the forkhead transcription factor DAF-16 in intestinal 
cells, known to function as the principal site of neutral lipid storage in this organism 
[212]. Following its translocation into the nucleus, DAF-16 has been shown to induce the 
expression of a gene encoding a specific lipase, thereby promoting the lipolysis of neutral 
lipids stored in LBs of intestinal cells and extending C. elegans longevity by a 
mechanism that remains to be defined [212]. Furthermore, the elimination of LBs- 
associated lipase Brummer in the fat body of flies or the abolition of ATGL (adipose 
triacylglycerol lipase) in WAT of mice has been demonstrated to shorten their lifespans 
[213, 214]. Moreover, the elimination of WAT-specific insulin receptor or the 







paralogue C/EBPβ has been shown to extend longevity in mice by greatly reducing the 
levels of neutral lipids stored in WAT [215 - 217]. 
As it has been discussed in section 1.3 of this thesis, a CR diet extends longevity in 
a wide spectrum of organisms and delays the onset of age-related diseases in mice and 
rhesus monkeys. The longevity-extending effects of this low-calorie diet in worms and 
flies are mediated by sirtuins, a family of NAD
+
-dependent protein deacetylases and ADP 
ribosylases [204, 216]. In mice, a CR diet is known to elevate the level of the sirtuin 
SIRT1, which has been shown to repress transcription of genes essential for the LBs- 
confined accumulation of neutral lipids in WAT [204, 218]. Based on these findings, it 
has been proposed that the beneficial effect of CR on longevity in mice is due in part to 
elevated abundance of SIRT1, which can cause longevity extension by shifting a balance 
between the opposing processes of LBs’ formation and degradation in WAT towards 
lipolytic degradation of neutral lipids in this fat storage tissue [204, 218]. 
In sum, these findings strongly support the view that the deposition and lipolytic 
degradation of neutral lipids confined to LBs in fat storage tissues define longevity of 
multicellular eukaryotic organisms. Recent studies suggested the following three 
mechanisms by which a delicate balance between the opposing processes of neutral lipids 
accumulation and their lipolytic degradation can regulate longevity in these organisms. 
First, the size of LBs in WAT of mice has been proposed to define the efficacy 
with which the ER in this tissue can synthesize and despatch for secretion various anti- 
hyperglycaemic and pro-hyperglycaemic protein hormones known to control metabolic 
homeostasis in other tissues [204, 205, 219, 220]. Of note, LBs that accumulate in 







the biosynthesis in the ER and subsequent secretion of the lipophilic hormones 
dafachronic acids and pregnenolone, both of which are known to delay cellular aging in 
other tissues [220]. It is likely therefore that the dynamics of deposition and lipolytic 
degradation of neutral lipids in LBs residing in fat storage tissues defines the efficacy 
with which these tissues can synthesize in the ER and then secrete humoral signals 
controlling longevity-extending and longevity-shortening processes in other tissues [181]. 
 
Second, it has been found that the lipolytic hydrolysis of neutral lipids deposited in 
LBs results in the release of the lipokine C16:1n7-palmitoleate, an unsaturated FFA, from 
WAT of mice [207]. C16:1n7-palmitoleate functions as a lipid hormone that regulates 
systemic carbohydrate and lipid homeostasis in muscle and liver by promoting muscle 
insulin sensitivity and attenuating hepatic steatosis [207]. It is conceivable therefore that, 
following its synthesis in and secretion by WAT of mice, C16:1n7-palmitoleate acts as a 
signaling molecule that plays an important role in longevity regulation [181]. 
Third, it has been shown that WAT of mice and the fat body of flies can respond to 
enhanced lipolysis of neutral lipids deposited in LBs residing in these tissues by 
activating certain regulatory networks known to stimulate mitochondrial biogenesis and 
 
β-oxidation of FFA in mitochondria [208, 217, 221]. The resulting decline of the levels of 
saturated FFA secreted by these fat storage tissues can reduce the risk of lipotoxicity in 
other tissues, thereby preventing muscle insulin resistance and hepatic steatosis [206 - 
208, 222]. It should be stressed that the stimulation of mitochondrial biogenesis and β- 
oxidation of FFA in WAT of mice expressing the β paralogue of C/EBP has been shown 
to extend longevity [217]. It is likely therefore that this third mechanism, which is 







peripheral tissues and increasing longevity of the entire organism [181]. 
 
Longevity can be extended and health can be improved not only by genetic, dietary 
and pharmacological interventions that specifically modulate the age-related dynamics of 
changes in the deposition and mobilization of neutral lipids. Cardiolipin (CL), a dimeric 
glycerophospholipid residing mainly in the inner mitochondrial membrane, has been 
shown to modulate mitochondria-governed processes whose dysfunction underlies aging 
and age-related pathologies [223 - 230]. Therefore, the synthesis and stability of CL and 
other glycerophospholipids in the inner mitochondrial membrane are important targets of 
longevity-extending and health-improving interventions. CL contains three glycerol 
backbones and four acyl chains [223 - 230]. It is well established that various molecular 
species of this signature lipid of the inner mitochondrial membrane control a number of 
vital processes by: (1) being associated with all five complexes of the mitochondrial 
respiratory chain, modulating their activities and promoting their organization into 
supramolecular assemblies; (2) binding to and modulating the activity of cytochrome c, a 
heme-containing mobile component of the mitochondrial respiratory chain also known 
for its essential role in mitochondria-controlled apoptosis; (3) being associated with and 
regulating adenine nucleotide translocator activity; (4) playing an important role in 
maintaining the electrochemical gradient across the inner mitochondrial membrane; (5) 
conferring fluidity and stability to the inner membrane of mitochondria; (6) being 
primary targets of ROS-inflicted damage because of their highly unsaturated acyl chains; 
and (7) regulating protein import into mitochondria [223 - 230]. Because of its propensity 
to associate via non-covalent interactions with numerous unrelated proteins in the inner 







a number of protein assemblies involved in wide spectrum of essential biological 
processes [224 - 230]. In addition, the conversion of CL to phosphatidic acid (PA) is one 
of the processes driving mitochondrial fission and fusion [231 - 233]. 
Specific changes in the content and/or composition of various molecular forms of 
CL have been revealed in pathological states characteristic of various disorders; many of 
these disorders impair mitochondria-confined processes known to be modulated by CL. 
For example, by lowering total CL levels, elevating concentrations of a monolyso form of 
CL and reducing the levels of its unsaturated fatty acyl species, certain mutations in 
human gene for tafazzin (an enzyme involved in the remodeling of CL acyl chains) cause 
an X-linked recessive disorder called Barth Syndrome [223, 225, 228]. Clinically, the 
Barth Syndrome manifests itself as cardioskeletal myopathy, neutropenia and abnormal 
growth [223, 225]. Furthermore, characteristic features of early stages of aging in mice 
and humans include reduced levels of CL and the resulting accumulation of dysfunctional 
mitochondria [224, 225, 228]. Noteworthy, due to the high content of vulnerable to 
oxidative damage unsaturated fatty acids in CL and because of the proximity of CL to the 
sites of ROS generation in mitochondria, this signature lipid of the inner mitochondrial 
membrane exhibits high susceptibility to mitochondrially generated ROS - whose levels 
are known to increase progressively with age [224, 226 - 229]. Other disorders associated 
with certain changes in the content and/or composition of CL include Tangier disease, 
diabetic cardiomyopathy, dilated cardiomyopathy with ataxia and non-alcoholic fatty 
liver disease [225, 228]. 
The molecular and cellular mechanisms underlying the essential role of CL in 







pathologies remain to be determined. One of such mechanisms may involve the CL- 
driven modulation of mitochondrial membrane proteins called prohibitins. The 
prohibitins Phb1p and Phb2p are evolutionarily conserved proteins that form multimeric, 
high-molecular weight complexes with each other in the inner mitochondrial membrane; 
these large complexes of Phb1p and Phb2p are known for their essential scaffolding 
function in maintaining the organization and functional integrity of this membrane [227, 
230, 234 - 237]. A body of evidence implies that prohibitins perform such scaffolding 
function by modulating activities of their numerous physically and/or functionally 
interacting protein partners, including: (1) proteins that are actively involved in the 
assembly of the respiratory chain; (2) proteins that are essential for both the maintenance 
of mitochondrial morphology and the assembly of β-barrel proteins in the outer 
membrane; (3) the m-AAA protease, an ATP-dependent protease with a critical role in 
protein quality control within the inner mitochondrial membrane; and (4) proteins that 
regulate, in a highly coordinated fashion,  the levels of CL and the glycerophospholipid 
phosphatidylethanolamine (PE) [227, 230, 234 - 237]. One of the major objectives of my 
studies described in this thesis was to establish molecular mechanisms underlying the 
ability of LCA, a natural longevity-extending compound, to delay yeast chronological 
aging by influencing the concentrations of CL (and, perhaps, of other mitochondrial 




1.5 Mitochondrial electron transfer chain (ETC) and mitochondrial theory of 
aging 







oxidative phosphorylation pathway and modulates the progression of programmed 
apoptotic cell death, thereby governing a plethora of cellular activities that are vital for a 
multicellular eukaryotic organism [238 - 241]. Initiated as early as in the beginning of 
1950s, studies aimed at understanding the importance of mitochondria in maintaining 
essential cellular processes provided the comprehensive evidence for the fundamental 
role of these organelles in regulating longevity of evolutionarily distant organisms [238, 
240]. For example, studies in chronologically aging yeast revealed that, by stimulating 
mitochondrial respiration, increasing the mitochondrial membrane potential and 
promoting mitochondrial ROS formation during logarithmic growth phase, a CR diet and 
some pharmacological interventions (including LCA) extend longevity by causing 
changes in a distinct set of longevity-defining processes during the subsequent diauxic, 
post-diauxic and stationary phases [25, 44, 46 - 49, 182]. Moreover, studies in the 
nematode C. elegans demonstrated that the efficacy of mitochondrial coupled respiration, 
the value of the electrochemical potential across the inner mitochondrial membrane and 
the extent of mitochondrial ATP production early in life, during the L3/L4 larval stage, 
define longevity by (1) causing the establishment of a specific configuration of the 
longevity-defining metabolic network later in life, during adulthood [51 - 56]; and (2) 
activating a retrograde signalling pathway that in response to mild mitochondrial 
impairment and stress during the L3/L4 larval stage activates expression of the 
mitochondria-specific unfolded protein response (UPR
mt
) genes in the nucleus, thereby 
stimulating synthesis of a subset of UPR
mt  
proteins known for their essential roles in 
longevity extension [57, 58]. In sum, by defining the efficacy of oxidative 







mitochondria, the electron transport chain (ETC) in the inner mitochondrial membrane 
plays a pivotal role in regulating longevity of organisms across phyla. 
Two models have been proposed for the organization of the mitochondrial ETC. 
One of these models, known as the random diffusion model or the fluid model, suggests 
that respiratory complexes move in a random fashion within the inner mitochondrial 
membrane [242]. Another model, which is currently accepted by most researchers in the 
field of mitochondrial bioenergetics, is known as the solid model. This model suggests 
that the respiratory complexes are assembled into larger supercomplexes within the inner 
mitochondrial membrane; these larger supramolecular structures are also called 
respirasomes [243 - 252]. Several important advantages of the supramolecular 
organization of respiratory complexes into supercomplexes have been proposed, 
including substrate channeling, catalytic enhancement and sequestration of reactive 
intermediates [243, 245 - 249, 252]. Substrate channeling is an efficient and beneficial 
process because it guides various intermediates of a biochemical process from one 
enzyme to another specific enzyme, thereby protecting every intermediate from being 
trapped by other enzymes; a body of evidence imply that this advantage is applicable to a 
mobile form of cytochrome c in yeast, bacterial and mammalian ETCs [243, 247, 248, 
251]. Thus, a supramolecular arrangement of individual respiratory complexes into 
supercomplexes/respirasomes enables a substantial catalytic enhancement of the ETC in 
the inner mitochondrial membrane [243 - 252]. 
It is well established that the first component of the mitochondrial ETC, NADH 
dehydrogenase (complex I) is responsible for the transfer of two electrons from NADH to 







accompanied by the shuttling of four protons from the mitochondrial matrix to the 
intermembrane space [240, 252, 253]. Succinate dehydrogenase (complex II) uses FAD 
to transfer two more electrons from succinate to the CoQ pool in the inner mitochondrial 
membrane [240, 241, 245, 253]. The cytochrome bc1 complex (complex III) then 
removes two electrons from the fully reduced CoQH2 at the Q0 site and carries them 
over to cytochrome c in the intermembrane space [240, 248 - 250, 253]. The other two 
electrons are carried over to the Qi site, where they are used to reduce the fully oxidized 
CoQ. In addition, complex III allows a shuttling of two protons to the intermembrane 
space as well as a pumping of two proteins from a full CoQ cycle [240, 242, 249, 253]. 
Cytochrome c oxidase (complex IV) then removes electrons from the reduced 
cytochrome c molecules in the exoplasmic face of the mitochondrial membrane and 
transfers them to oxygen in the mitochondrial matrix through a series of electron transfers 
to produce water [240, 253]. Complex IV also allows the translocation of two additional 
protons out of the matrix [241, 253]. The efflux of ten protons per a single reduced 
NADH molecule creates an electrochemical gradient that provides energy for ATP 
synthesis by the F0F1 complex (Complex V) in a process known as oxidative 
phosphorylation [240 -242, 249, 253]. 
It is well established that ROS, mainly produced as a by-product of the electron 
transfer through mitochondrial respiratory chain, play a pivotal role in longevity 
regulation in organisms across phyla [238, 240, 241, 253]. In 1972, Denham Harman 
proposed the mitochondrial free radical theory of aging, which was inspired by a body of 
evidence for the progressive accumulation of mitochondrially generated ROS with cell 







demonstrated ROS toxicity in living cells [255] and on the discovery that the ROS- 
generating respiratory chain is confined solely to the inner mitochondrial membrane [256, 
257]. Most of the known targets for the oxidative macromolecular damage caused by 
ROS are mitochondrial proteins, DNA and lipids, including (1) aconitase, a [4Fe-4S] 
cluster enzyme of the tricarboxylic acid (TCA) cycle; (2) Lys4p, a [4Fe-4S] cluster 
enzyme of lysine biosynthesis that takes place in the mitochondrion; (3) succinate 
dehydrogenase (SDH), a [3Fe-3S] cluster- and heme-containing enzyme of the TCA that 
also functions as complex II of the ETC in the inner mitochondrial membrane; (4) 
cytochrome c, a heme-containing mobile  component  of  the mitochondrial  ETC;  (5) 
cytochrome c oxidase, a heme-containing complex IV of the mitochondrial ETC; (6) the 
mitochondrial DNA (mtDNA) nucleoid that, in contrast to chromatin in the nucleus, lacks 
histones; and (7) saturated fatty acids of membrane lipids [182, 240, 253, 258 - 261]. 
According to the mitochondrial free radical theory of aging, the gradual accumulation of 
macromolecular damage caused by mitochondrially produced ROS throughout lifespan 
accelerates cellular dysfunction and later in life leads to a functional decline and 
increased mortality [254, 255]. Although a body of evidence does not validate the core 
statement of this theory on a casual role of ROS generation in aging, the importance of 
ROS in mediating a longevity-extending stress response to age-related cellular damage is 
supported by numerous findings [262 -267]. Indeed, while high intracellular and 
intraorganellar levels of ROS can cause oxidative damage to various cellular constituents, 
low concentrations of intracellular ROS can activate cellular processes that protect 
cellular macromolecules from oxidative damage [182, 240, 253, 262 - 267]. Furthermore, 
 







related form of programmed apoptotic cell death [182, 240, 253, 262 - 267]. A term 
“hormesis” has been coined to describe longevity extension in response to a mild stress 
caused by low levels of mitochondrially produced ROS [262 - 267]. 
One of the major objectives of studies described in my thesis was to investigate 
how LCA, a natural anti-aging compound, as well as genetic interventions altering the 
synthesis of CL and other glycerophospholipids in the inner mitochondrial membrane 
influence the supramolecular organization of mitochondrial ETC. Our recent unpublished 
findings suggested that LCA could modulate the stoichiometry, composition and/or 
functional state of respiratory supercomplexes (respirasomes) in the inner mitochondrial 
membrane, perhaps by altering the level of CL and other glycerophospholipids within 
this membrane (Koupaki et al., manuscript in preparation). We hypothesized that such 
LCA- and CL-dependent remodeling of the mitochondrial respiratory supercomplexes (1) 
may rely on a distinct set of protein components of the respiratory complexes that 
compose the respirasomes; (2) may alter the age-dependent dynamics of mitochondrial 
respiration, oxidative phosphorylation, ADP/ATP exchange, ATP synthesis, membrane 
potential and/or ROS generation; (3) may occur in an age-dependent fashion; and (4) may 
extend longevity by increasing the efficiency of ATP synthesis in chronologically aging 
yeast and/or specifically altering the age-dependent dynamics of changes in 




1.6  Thesis outline and contributions of colleagues 
Chapter 2 of my thesis describes how we used mass spectrometry (MS)-based lipidomics 






mitochondria that were purified from wild-type (WT) strain and from various long- and 
short-lived mutant strains impaired in different aspects of cardiolipin (CL) and 
phosphatidylethanolamine (PE) metabolism. By correlating the effects of LCA on the 
age-related dynamics of changes in the composition and quantities of membrane lipids in 
mitochondria of these strains to the effects of this anti-aging compound on their 
chronological lifespan, we concluded that under caloric restriction (CR) conditions LCA 
extends yeast longevity by remodeling the composition of mitochondrial membrane lipids 
and thereby modulating longevity-defining processes confined to and governed by 
mitochondria. Specifically, findings described in Chapter 2 strongly suggest that LCA 
extends longevity of WT yeast by (1) elevating the level of phosphatidylserine (PS; a 
precursor for the synthesis of PE in mitochondria) in the mitochondrial membrane, 
thereby enhancing its positive effect on longevity-defining processes in this membrane; 
(2) reducing the level of PE in the mitochondrial membrane, thereby weakening its 
negative effect on longevity-defining processes in this membrane; and (3) proportionally 
decreasing the levels of PE and CL in the mitochondrial membrane, thereby increasing 
PS/CL and PS/PE ratios but maintaining PE/CL ratio of mitochondrial membrane lipids 
and causing some longevity-extending changes in this membrane. These LCA-induced 
alterations in mitochondrial membrane lipids can satisfactorily explain the observed 
implications of LCA treatment on mitochondrial structure and function, including (1) the 
ability of LCA to cause dramatic changes in the length and curvature of the inner 
mitochondrial membrane; and (2) the ability of LCA to activate protein machines 
involved in mitochondrial respiration, the maintenance of mitochondrial membrane 







Based on our findings described in Chapter 2 of my thesis and data of other 
researchers working in the field of mitochondrial biology, we hypothesized that, by 
altering the level of CL and other glycerophospholipids within the mitochondrial 
membrane, LCA could modulate the stoichiometry, composition and/or functional state 
of respiratory supercomplexes (respirasomes) in the inner mitochondrial membrane. To 
test the validity of this hypothesis, in studies described in Chapter 3 of my thesis we used 
a multistep method for recovery of intact respiratory complexes and supercomplexes 
from purified yeast mitochondria, their subsequent first-dimension electrophoretic 
separation using so-called blue-native gel electrophoresis (BN-PAGE), their resolution 
into individual protein components with the help of denaturing Tricine-SDS-PAGE, and 
the mass spectrometry (MS)-based identification of each of these individual protein 
components. Findings described in this chapter of my thesis validate our hypothesis. 
Specifically, these findings revealed several ways of rearranging respiratory 
supercomplexes in the inner mitochondrial membrane of cells exhibiting altered 
mitochondrial membrane lipidome in response to LCA treatment or genetic 
manipulations impairing the synthesis of CL and other glycerophospholipids within the 
inner membrane of mitochondria. First, by altering the level of CL and other 
glycerophospholipids synthesized and residing in the inner mitochondrial membrane, 
LCA modulates the abundance of several major respiratory supercomplexes 
(respirasomes) in this membrane. Second, LCA- and genetic manipulations-driven 
changes in the inner mitochondrial membrane lipidome cause a recruitment of a number 
of new mitochondrial protein components, not previously known for being permanently 







proteins newly recruited into the remodeled respirasomes are known for their essential 
roles in mitochondria-confined processes that define longevity. 
Findings described in Chapter 2 are presented in the manuscript of a paper 
[Bourque, S.D.*, Koupaki, O.*, Richard, V.R., Beach, A., Burstein, M.T., Kyryakov, P. 
and Titorenko, V.I. Lithocholic acid extends yeast longevity in part by altering the 
composition of mitochondrial membrane lipids; * Equally contributed first co-authors] 
that is currently in preparation for submission to Current Biology. I expect this 
manuscript to be submitted for publication in late September or early October of 2012. I 
carried out more than 30% of the work described in this publication and prepared the first 
draft of sections relevant to my work. I am an equally contributed first co-author on this 
publication. Dr. V. Titorenko provided intellectual leadership of this project and is 
currently editing the manuscript. 
All abbreviations, citations, and the numbering of figures and tables that have 
been used in the published papers and in the manuscripts in preparation have been 





























2 Lithocholic acid (LCA) extends longevity of chronologically aging yeast by 






Recent studies in our laboratory demonstrated that in chronologically aging yeast grown 
under CR conditions LCA, a natural anti-aging compound, alters the age-related 
dynamics of changes in mitochondrial abundance and morphology, respiration, 
membrane potential, and ROS production. Cardiolipin (CL), a dimeric 
glycerophospholipid that is synthesized and almost exclusively localized in the inner 
mitochondrial membrane, has been shown to modulate mitochondria-governed processes 
whose dysfunction underlies aging and age-related pathologies [223 - 230]. 
Phosphatidylethanolamine (PE) is another glycerophospholipid that is almost exclusively 
synthesized in the inner mitochondrial membrane, from which it is then distributed to 
various other cellular membranes [268, 269]. Hence, it is likely that the synthesis and 
stability of CL and, perhaps, PE in the inner mitochondrial membrane are important 
targets of longevity-extending and health-improving interventions. Because of the 
plausible importance of mitochondrially synthesized CL and PE in the longevity- 
extending effect of LCA, other graduate students in our laboratory elucidated how 
mutations eliminating nucleus-encoded mitochondrial proteins involved in the synthesis 
of CL and PE within the inner mitochondrial membrane influence the lifespan-extending 
efficacy of LCA in chronologically aging yeast grown under CR conditions. The results 
of this genetic analysis suggested that the synthesis of both these membrane lipids in 







placed on a CR diet. All these findings prompted us to elucidate how LCA influences the 
composition of mitochondrial membrane lipids in chronologically aging yeast grown 
under CR conditions. To attain this objective, in experiments described in this chapter of 
my thesis we used mass spectrometry (MS)-based lipidomics to elucidate the effect of 
LCA on the repertoire and quantities of membrane lipids in mitochondria that were 
purified from wild-type (WT) strain and from various long- and short-lived mutant strains 
impaired in different aspects of CL and PE metabolism. By correlating the effects of 
LCA on the age-related dynamics of changes in the composition and quantities of 
membrane lipids in mitochondria of these strains to the effects of this anti-aging 
compound on their chronological lifespan, we concluded that under CR conditions LCA 
extends yeast longevity by remodeling the composition of mitochondrial membrane lipids 
and thereby modulating longevity-defining processes confined to and governed by 
mitochondria. Specifically, findings described here strongly suggest that LCA extends 
longevity of WT yeast by (1) elevating the level of phosphatidylserine (PS; a precursor 
for the synthesis of PE in mitochondria) in the mitochondrial membrane, thereby 
enhancing its positive effect on longevity-defining processes in this membrane; (2) 
reducing the level of PE in the mitochondrial membrane, thereby weakening its negative 
effect on longevity-defining processes in this membrane; and (3) proportionally 
decreasing the levels of PE and CL in the mitochondrial membrane, thereby increasing 
PS/CL and PS/PE ratios but maintaining PE/CL ratio of mitochondrial membrane lipids 
and causing some longevity-extending changes in this membrane. It is important to 
emphasize that these LCA-induced alterations in mitochondrial membrane lipids can 







structure and function, including (1) the ability of LCA to cause dramatic changes in the 
length and curvature of the inner mitochondrial membrane; and (2) the ability of LCA to 
activate protein machines involved in mitochondrial respiration, the maintenance of 







It is well established that various molecular species of CL, a signature lipid of the inner 
mitochondrial membrane, control a number of vital processes by: (1) being associated 
with all five complexes of the mitochondrial respiratory chain, modulating their activities 
and promoting their organization into supramolecular assemblies; (2) binding to and 
modulating the activity of cytochrome c, a heme-containing mobile component of the 
mitochondrial respiratory chain also known for its essential role in mitochondria- 
controlled apoptosis; (3) being associated with and regulating adenine nucleotide 
translocator activity; (4) playing an important role in maintaining the electrochemical 
gradient across the inner mitochondrial membrane; (5) conferring fluidity and stability to 
the inner membrane of mitochondria; (6) being primary targets of ROS-inflicted damage 
because of their highly unsaturated acyl chains; and (7) regulating protein import into 
mitochondria [223 - 230]. Because of its propensity to associate via non-covalent 
interactions with numerous unrelated proteins in the inner mitochondrial membrane, CL 
acts as a molecular chaperone that governs the assembly of a number of protein 










addition, the conversion of CL to phosphatidic acid (PA) is one of the processes driving 
mitochondrial fission and fusion [231 - 233]. 
Specific changes in the content and/or composition of various molecular forms of 
CL have been revealed in pathological states characteristic of various disorders; many of 
these disorders impair mitochondria-confined processes known to be modulated by CL 
[223 - 225, 228]. Furthermore, characteristic features of early stages of aging in mice and 
humans include reduced levels of CL and the resulting accumulation of dysfunctional 
mitochondria [224, 225, 228]. Noteworthy, due to the high content of vulnerable to 
oxidative damage unsaturated fatty acids in CL and because of the proximity of CL to the 
sites of ROS generation in mitochondria, this signature lipid of the inner mitochondrial 
membrane exhibits high susceptibility to mitochondrially generated ROS - whose levels 
are known to increase progressively with age [224, 226 - 229]. Moreover, we recently 
found that a longevity-extending CR diet reduces the level of CL in the mitochondrial 
membrane of chronologically aging yeast [25]. In sum, it is quite likely that the synthesis 
and stability of CL (and, perhaps, PE and other glycerophospholipids) in the inner 
mitochondrial membrane play an essential role in regulating various mitochondria- 
confined processes whose dysfunction underlies aging and age-related pathologies. 
However, the molecular mechanisms underlying such essential role for CL and other 
mitochondrial membrane glycerophospholipids in modulating longevity-defining 
mitochondrial processes are yet to be established. As a first step towards defining these 
mechanisms, in experiments described in this chapter of my thesis we used MS-based 
lipidomics to elucidate the effect of LCA on the composition and quantities of membrane 







mutant strains impaired in different aspects of the metabolism of CL and other 




2.3 Materials and Methods 
 
Strains and media 
 
The wild-type strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 lys20 
ura30) and mutant strains ups1 (MAT his31 leu20 lys20 ura30 
ups1::kanMX4), taz1 (MAT his31 leu20 lys20 ura30 taz1::kanMX4), gep1 
(MAT his31 leu20 lys20 ura30 gep1::kanMX4), psd1 (MAT his31 leu20 
lys20 ura30 psd1::kanMX4) and crd1 (MAT his31 leu20 lys20 ura30 
crd1::kanMX4) were used in this study. Yeast were grown in in YP medium (1% yeast 
extract, 2% peptone) initially containing 0.2% glucose as carbon source. Cells were 
cultured at 30
o
C with rotational shaking at 200 rpm in Erlenmeyer flasks at a “flask 








1. Dithiothreitol (DTT) buffer [100 mM Tris-H2SO4, 10 mM dithiothreitol] 
 
2. Zymolyase 100T from Arthrobacter luteus (MP Biomedicals) 
 
3. Zymolyase buffer [1.2 M sorbitol, 20 mM potassium phosphate] 
 
4. Homogenization buffer [0.6 M sorbitol, 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 0.2% 
(w/v) BSA] 








Cell cultures were combined in pre-weighed centrifuge bottles and cells were pelleted at 
 
3,000 × g for 5 min at room temperature using a Beckman JA-10 rotor. The cells were 
washed twice with distilled water, followed by the determination of their wet weight. The 
cell pellets were resuspended in 2 ml/g DTT buffer and incubated on a shaker at 80 rpm 
for 20 min at 30ºC. The cells were pelleted as per initial centrifugation, washed in 7 ml/g 
Zymolyase buffer without Zymolyase and pelleted once more. The cells were incubated 
on a shaker at 80 rpm for 45 min at 30ºC with 1 mg/g (wet weight) of Zymolyase-100T in 
 
7 ml/g Zymolyase buffer. Zymolyase was used because of its well-known strong lytic 
activity required to digest yeast cell wall. The spheroplasts obtained were then spun down 
at 2,200 × g for 8 min at 4ºC. All subsequent steps were carried out on ice or at 4°C with 
the use of cut pipette tips to avoid breaking organelles. The spheroplasts were 
resuspended in 6.5 ml/g ice-cold homogenization buffer and washed by centrifugation at 
 
2,200 × g for 8 min at 4ºC. The spheroplasts were then mechanically homogenized with 
 
15 strokes in 6.5 ml/g ice-cold homogenization buffer to disrupt yeast plasma membrane 
for releasing organelles and cytoplasm. Following the homogenization, the cell debris 
was pelleted by centrifuging at 1,500 × g for 5 min at 4ºC using a Beckman JA-17 rotor. 
The resulting lysate supernatant was subjected to centrifugation twice at 3000 × g for 5 
min at 4ºC to pellet the nuclei and 12,000 × g for 15 min at 4ºC. The newly obtained 
pellet contains mostly mitochondria, but also the endoplasmic reticulum (ER), Golgi, 
peroxisomes, lysosomes and vacuoles, whereas the supernatant contains the cytosol, 
microsomes from the ER and vacuoles. The pellet was resuspended in 6.5 ml/g in ice- 







supernatant containing mitochondria, which was then subjected to a spin at 12, 000 × g 
for 15 min at 4ºC. The resulting pellet was resuspended in 3 ml of SEM to be overlaid 








1. SEM buffer [250 mM sucrose, 1 mM EDTA, 10 mM Mops (pH 7.2)] 
 







In order to purify yeast mitochondria from the crude mitochondrial fraction, an 
equilibrium density-gradient centrifugation was performed. Yeast mitochondria have a 
density of 1.18 g/cm
3  





. To prepare a sucrose density gradient for the purification of 
 
mitochondria, 1.5 ml of 60% sucrose in EM buffer was overlaid with 4 ml of 32%, 1.5 ml 
of 23% and 1.5 ml of 15% sucrose in EM buffer, followed by 3 ml of the crude 
mitochondrial suspension. The sucrose density gradient containing the mitochondrial 
suspension was subjected to centrifugation in a Beckman SW41 Ti swinging-bucket rotor 
at 134,000 × g for 60 min at 4ºC.  The mitochondrial band, which was easily 
distinguishable, appeared at the interface between 60% and 32% sucrose. Fractions of 1 
ml were recovered using a cut pipette tip and placed in 1.5 ml Eppendorf tubes and 







fractions were immersed, with the aid of long tweezers, in a beaker of isopropyl alcohol 




Analysis of lipids by mass spectrometry 
 
4 ml of SEM buffer were added to a 1-ml sucrose density gradient peak fraction 
containing highly purified mitochondria. The mitochondria were pelleted by 
centrifugation in a Beckman MLS50 swinging-bucket rotor at 100,000 × g for 30 min at 
4ºC. The lipids were extracted by resuspending the pellet of mitochondria in 3.8 ml of 
chloroform - methanol - water (1:2:0.8) and by vortexing the suspension with glass beads 
three times for 1 min. 1 ml of chloroform was then added, and the extract was incubated 
for 5 min with occasional mixing. 1 ml of water was then added, and the extract was 
incubated for 5 min with occasional mixing. The extract was centrifuged and the entire 
supernatant was collected. The pellet was resuspended in 1.6 ml of chloroform, and the 
lipids were extracted by vortexing the suspension with glass beads two times for 1 min. 
The extract was then centrifuged and the entire supernatant was collected. The pooled 
supernatants were centrifuged and the organic phase was collected. The lipid extract was 
dried under nitrogen. The lipid film was dissolved in 400 μl of chloroform - methanol 
(1:1) containing either 3 mM ammonium hydroxide for positive-ion analyses or no 
additive for negative-ion measurements. 
Mass spectrometric analyses were performed with a Micromass Q-TOF 2 mass 
spectrometer that was used in the single-stage mass spectrometry mode for positive- or 
negative-ion analyses as follows: 







lipids in 200 µl of methanol - chloroform (1:1) with 0.1% ammonium hydroxide. The 
standard to sample ratio can be changed as needed. 
2. Resolve lipids using a Micromass Q-TOF 2 mass spectrometer equipped with a 
nano-electrospray source operating at a flow rate of 1 μl/min. Although we have taken 
advantage of the high resolution of a Q-TOF type of mass spectrometer, it is not a 
mandatory requirement. Exact instrument parameters will vary from instrument to 
instrument. See Table 2.1 for the settings for a Micromass Q-ToF 2 (Waters, Milford, 
MA, USA) equipped with a nano-electrospray source. To analyze PC and TAG, the cone 
voltage was set to 28 v and the capillary voltage to 3.0 kv in positive mode. For the 
analysis of FFA, CL, PE, PS, PA and PI, the cone voltage was set to 30 v and the 
capillary voltage to 3.2 kv in negative mode. In both modes, the collision gas was set to 
10 (arbitrary units). Survey MS data were acquired for up to 3 minutes or until the ion 






Table 2.1. Instrument settings for a Micromass Q-ToF 2 (Waters, Milford, MA, USA) 
 
equipped with a nano-electrospray source. 
 


















For quantification of individual lipid molecular species, the commercially available 
 







known to be absent in yeast cells (see Table 2.2). Various molecular forms of the 
glycerophospholipids phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylinositol (PI), phosphatidylserine (PS) and phosphatidic acid (PA), as well as 
of cardiolipin (CL), were from Avanti Polar Lipid (Alabaster, AL, USA). Different 





Table 2.2. Internal lipid standards, their concentrations in the standard mix and the MS 
 
mode for their analysis.  




















































































After acquisition, the mass spectra were smoothed and background subtracted and 
centred using the MassLynx software package (Waters, Milford, MA, USA). The peak 







was first searched using equation 2.1 to determine the peaks of interest. The resulting 
peak list was then deconvoluted and deisotoped using a lookup table, which represented 
the relative intensities of the isotope peaks. The peak list was first scanned specifically 
for CL species and, using the I1  isotope, the contribution of these lipid species to isobaric 
peaks was determined and subtracted. The peak list was then scanned for other lipid 
classes from low to high mass, the peaks deisotoped and the contribution to isobaric 
isotope peaks subtracted. Peak intensities were then normalized to the internal standard of 
the appropriate lipid class. The molecular forms of various lipid classes detected 





Equation 2.1. The following Excel function was used to search the column 
LookUpVector and return the corresponding value in the column ResultsVector, which 









Table 2.3. The molecular forms of various lipid classes detected following lipid 







































































































































PI 34:2 833.52 
 32:0 809.52 
 32:1 807.50 
 32:2 805.49 
 30:0 781.49 
 30:1 779.47 
 30:2 777.46 
 28:0 753.46 
 28:1 751.44 
 28:2 749.42 
 38:0 790.56 
 38:1 788.54 
 38:2 786.53 
PS 36:0 762.53 
 36:1 760.51 
 36:2 758.50 






















































































































































































































































































































































2.4.1 LCA alters the concentrations of membrane lipids and their relative 
abundance in mitochondria of WT cells 
The individual steps of the partially overlapping biosynthetic pathways for CL and PE in 
the inner membrane of yeast mitochondria, as well as mitochondrial proteins catalyzing 
or regulating each of these steps, are well established (Figure 2.1) [268 - 273]. To assess 
a role of CL and other mitochondrial membrane lipids in the longevity-extending ability 
of LCA, other graduate students in our laboratory recently tested if LCA can increase the 
CLS of various single-gene-deletion mutants lacking nuclear genes that encode different 
mitochondrial proteins involved in the synthesis of CL and PE within the inner 
mitochondrial membrane (Figure 2.1). These studies revealed that mutations eliminating 
the Crd1p, Taz1p, Psd1p, Ups1p or Gep1p mitochondrial proteins involved in the 
synthesis of CL and PE within the mitochondrial inner membrane differentially alter the 
ability of LCA to extend the CLS of yeast grown under CR conditions on 0.2% glucose. 
Specifically, it was found that LCA is unable to extend the CLS of the ups1 mutant 









Figure 2.1. Outline of the biosynthesis of cardiolipin (CL), phosphatidylglycerol (PG), 
phosphatidylethanolamine (PE) and phosphatidylserine (PS) from phosphatidic acid (PA) in the inner 
mitochondrial membrane. PA is delivered to the mitochondrial inner membrane from the mitochondria- 
associated membrane (MAM) domain of the endoplasmic reticulum (ER), where it is synthesized. PA is 
then converted to cytidine diphosphodiacylglycerol (CDP-DAG), which serves as a precursor for synthesis 
of both CL and PE in the inner mitochondrial membrane. It has been proposed that both CL and PE 
modulate the ability of prohibitins Phb1p and Phb2p - two evolutionarily conserved proteins that form large 
complexes with each other in the mitochondrial inner membrane - to maintain the organization and 
functional integrity of this membrane [268 - 273]. Other abbreviations: PG-P, phosphatidylglycerol 




also found that LCA is unable to extend the CLS of the taz1 mutant, which lacks an 
enzyme catalyzing the conversion of MLCL to CL (Figure 2.1). Furthermore, these 
studies also revealed that the gep1 mutation, which eliminates a protein regulating the 
biosynthesis of CL and PE (Figure 2.1), enhances the ability of LCA to extend the CLS 
of yeast under CR conditions. Moreover, it was showed that the psd1 mutation, which 










Figure 2.2. Effect of LCA on the age-related dynamics of changes in the total levels of CL, PE, PS and 
MLCL in the membranes of mitochondria purified from WT cells. Yeast were grown in YP medium 
initially containing 0.2% glucose as carbon source,  without LCA or with this bile acid (used in the 
concentration of 50 μM), and collected for the purification of mitochondria at days 2, 3 or 4. Mitochondrial 




of LCA to extend longevity of chronologically aging yeast grown under CR conditions. 
In addition, these studies demonstrated that the crd1 mutation, which eliminates an 









Figure 2.3. Effect of LCA on the age-related dynamics of changes in PE/CL, PS/CL and PS/PE ratios in 
the membranes of mitochondria purified from WT cells. Yeast were grown in YP medium initially 
containing 0.2% glucose as carbon source,  without LCA or with this bile acid (used in the concentration of 
50 μM), and collected for the purification of mitochondria at days 2, 3 or 4. Mitochondrial membrane lipids 




extend the CLS of yeast grown under CR conditions. 
 
In sum, these data suggested that the rates of synthesis of CL and PE from their 
precursors PG and PS (respectively), as well as the rate of remodeling of acyl chains of 
CL by the sequential action of a phospholipase A (converting CL to MLCL) and a 
transacylation reaction catalyzed by Taz1p (Figure 2.1), within the inner mitochondrial 
membrane define the longevity-extending efficacy of LCA. We therefore hypothesized 
that one of the mechanisms underlying the ability of LCA to extend yeast longevity 
consists in the LCA-driven remodeling of the mitochondrial membrane by altering the 








Figure 2.4. Effect of LCA on the levels of various molecular forms of CL in the membranes of 
mitochondria purified from WT cells. Yeast were grown in YP medium initially containing 0.2% glucose 
as carbon source,  without LCA or with this bile acid (used in the concentration of 50 μM), and collected 
for the purification of mitochondria at day 4. Mitochondrial membrane lipids were identified and 
quantitated by MS as described in Materials and Methods. The term “spike” refers to a commercially 
available non-yeast molecular form of CL that was used for the MS-based quantitation of CL species in 




abundance of certain molecular species of these membrane lipids. In our hypothesis, such 
LCA-driven remodeling of the composition of mitochondrial membrane lipids extends 
the CLS of CR yeast by modulating longevity-defining processes confined to and/or 
governed by mitochondria. To test the validity of this hypothesis, we used MS-based 







Figure 2.5. Effect of LCA on the levels of various molecular forms of PE in the membranes of 
mitochondria purified from WT cells. Yeast were grown in YP medium initially containing 0.2% glucose 
as carbon source,  without LCA or with this bile acid (used in the concentration of 50 μM), and collected 
for the purification of mitochondria at day 4. Mitochondrial membrane lipids were identified and 
quantitated by MS as described in Materials and Methods. The term “spike” refers to a commercially 
available non-yeast molecular form of PE that was used for the MS-based quantitation of PE species in 
purified yeast mitochondria. 
 
 
levels of CL, PE, PS and MLCL in the membrane of mitochondria purified from WT 
cells (Of note, because CDP-DAG, PG-P and PG do not accumulate in significant 
amounts in mitochondrial membranes under normal conditions [268, 269], these 
important intermediates for the synthesis of CL, PE, PS and MLCL within the inner 







Figure 2.6. Effect of LCA on the levels of various molecular forms of PS in the membranes of 
mitochondria purified from WT cells. Yeast were grown in YP medium initially containing 0.2% glucose 
as carbon source,  without LCA or with this bile acid (used in the concentration of 50 μM), and collected 
for the purification of mitochondria at day 4. Mitochondrial membrane lipids were identified and 
quantitated by MS as described in Materials and Methods. The term “spike” refers to a commercially 
available non-yeast molecular form of PS that was used for the MS-based quantitation of PS species in 




mitochondria purified from WT cells; we were able to detect PG accumulation by MS 
only in mitochondria purified from the crd1 mutant, which lacks an enzyme catalyzing 
the synthesis of CL from PG and CDP-DAG). We found that LCA reduces the total 
levels and the levels of several molecular forms of CL (Figures 2.2 and 2.4), PE (Figures 










Figure 2.7. Effect of LCA on the levels of various molecular forms of MLCL in the membranes of 
mitochondria purified from WT cells. Yeast were grown in YP medium initially containing 0.2% glucose 
as carbon source,  without LCA or with this bile acid (used in the concentration of 50 μM), and collected 
for the purification of mitochondria at day 4. Mitochondrial membrane lipids were identified and 
quantitated by MS as described in Materials and Methods. 
 
 
the levels of several molecular forms of PS (Figures 2.2 and 2.6). The observed effect of 
LCA on the quantities of CL, PE and PS enables to maintain PE/CL ratio in the 
mitochondrial membrane (Figure 2.3). Furthermore, our MS-based lipidomic analysis 
revealed that, by elevating the total level of PS, LCA greatly increases PS/CL and PS/PE 
ratios in the membrane of WT mitochondria (Figure 2.3). Altogether, these findings 




biosynthesis of CL and PE (respectively) in the inner mitochondrial membrane, thereby 
reducing the quantities of these two lipid classes and increasing the quantity of PS, a 






Figure 2.8. Findings described in section 2.4.1 of my thesis suggest a hypothesis in which LCA inhibits the 
Crd1p- and Psd1p-driven reactions of the biosynthesis of CL and PE (respectively) in the inner 
mitochondrial membrane, thereby reducing the quantities of these two lipid classes and increasing the 




2.4.2 The LCA-driven remodeling of the mitochondrial membrane by altering the 
concentrations and relative abundances of CL, PE and PS is essential for the 
longevity-extending ability of LCA and defines its efficacy 
According to our hypothesis on the inhibition by LCA of the Crd1p- and Psd1p-driven 
 







Figure 2.9. LCA cannot extend the chronological lifespan of the ups1 mutant whose mitochondrial 
membrane has greatly elevated (as compared to WT strain) PE/CL ratio, in spite of the ability of LCA to 
reduce this ratio in the mitochondrial membranes of ups1. Yeast were grown in YP medium initially 
containing 0.2% glucose as carbon source,  without LCA or with this bile acid (used in the concentration of 
50 μM), and collected for the purification of mitochondria at day 4. Mitochondrial membrane lipids were 




membrane (Figure 2.8), the caused by LCA reduction of the levels of CL and PE and 
increase of the quantity of PS is essential for the longevity-extending ability of this bile 
acid and defines its efficacy as an anti-aging compound. We tested the validity of this 
hypothesis by using MS-based lipidomics for the identification and quantitation of 
various species of CL, PE and PS extracted from purified mitochondria of ups1, taz1, 
psd1 or gep1 mutant cells grown in medium without LCA or with LCA (used in the 
concentration of 25 μM or 50 μM) and collected at days 2, 3 or 4. Our comparative MS- 
assisted lipidomic analysis leads to the following conclusions. First, although LCA 









Figure 2.10. LCA cannot extend the chronological lifespan of the taz1 mutant whose mitochondrial 
membrane has greatly elevated (as compared to WT strain) PE/CL ratio, in spite of the ability of LCA to 
reduce this ratio in the mitochondrial membranes of taz1. Yeast were grown in YP medium initially 
containing 0.2% glucose as carbon source,  without LCA or with this bile acid (used in the concentration of 
50 μM), and collected for the purification of mitochondria at day 4. Mitochondrial membrane lipids were 




ratio in the mitochondrial membrane of LCA-treated ups1 mutant cells remains 
significantly elevated as compared to that in the mitochondrial membrane of WT cells 
(Figure 2.9); importantly, LCA has been found to be unable to extend longevity of the 
ups1 mutant strain (Figure 2.9). Second, although LCA reduces PE/CL ratio in the 
mitochondrial membranes of taz1 (Figure 2.10), this ratio in the mitochondrial 
membrane of LCA-treated taz1 mutant cells remains significantly elevated as compared 
to that in the mitochondrial membrane of WT cells (Figure 2.10); importantly, LCA is 
unable to extend longevity of the taz1 mutant strain (Figure 2.10). Third, PE/CL ratio in 










Figure 2.11. The ability of LCA to extend chronological lifespan is enhanced in the psd1 mutant strain in 
which (1) PE/CL ratio in the mitochondrial membrane is at the same level as that in WT strain; and (2) both 
PS/CL and PS/PE ratios in the mitochondrial membrane are significantly increased (as compared to those 
in WT strain) in LCA-treated and untreated cells. Yeast were grown in YP medium initially containing 
 
0.2% glucose as carbon source,  without LCA or with this bile acid (used in the concentration of 50 μM), 
and collected for the purification of mitochondria at day 4. Mitochondrial membrane lipids were identified 




that in WT cells (Figure 2.11), whereas both PS/CL and PS/PE ratios in the inner 
mitochondrial membrane of LCA-treated psd1 cells are significantly elevated as 
compared to those in the mitochondrial membrane of WT cells (Figure 2.11); 
importantly, we found that the longevity-extending efficacy of LCA is enhanced in the 
psd1 mutant strain (Figure 2.11). Fourth, PE/CL ratio in the inner mitochondrial 
membrane of LCA-treated gep1 mutant cells is at the same level as that in WT cells 
(Figure 2.12), whereas both PS/CL and PS/PE ratios in the inner mitochondrial 







Figure 2.12. The ability of LCA to extend chronological lifespan is enhanced in the gep1 mutant strain in 
which (1) PE/CL ratio in the mitochondrial membrane is at the same level as that in WT strain; and (2) both 
PS/CL and PS/PE ratios in the mitochondrial membrane are significantly increased (as compared to those 
in WT strain) in LCA-treated and untreated cells. Yeast were grown in YP medium initially containing 
 
0.2% glucose as carbon source,  without LCA or with this bile acid (used in the concentration of 50 μM), 
and collected for the purification of mitochondria at day 4. Mitochondrial membrane lipids were identified 




compared to those in the mitochondrial membrane of WT cells exposed to LCA or 
remained untreated (Figure 2.12); importantly, the longevity-extending efficacy of LCA 
is enhanced in the gep1 mutant strain (Figure 2.12). 
In sum, findings described in this section of my thesis strongly suggest that LCA 
extends longevity of chronologically aging yeast under CR conditions by (1) increasing 
the level of PS (a precursor for the synthesis of PE in mitochondria) in the mitochondrial 
membrane, thereby enhancing its positive effect on longevity-defining processes in this 
membrane; (2) decreasing the level of PE in the mitochondrial membrane, thereby 





proportionally decreasing the levels of PE and CL in the mitochondrial membrane, 
thereby increasing PS/CL and PS/PE ratios but maintaining PE/CL ratio of mitochondrial 




2.4.3 LCA alters the levels of the inverted cone-shaped and cone-shaped species of 
 
PS, CL and PE known to affect membrane curvature 
 
Our MS analysis revealed that LCA alters the levels of various molecular forms of CL 
(Figure 2.4), PE (Figure 2.5) and PS (Figure 2.6) in the mitochondrial membrane of WT 
cells grown under CR conditions. These findings suggest that by causing these changes 
LCA is likely to alter the curvature of the inner mitochondrial membrane, thereby 
affecting its ability to form cristae, contact sites or remain flat and, as a result, 
specifically modulating the longevity-defining morphology and functional state of 
mitochondria. Indeed, LCA decreases the level of the cone-shaped species of CL 
enriched in unsaturated fatty acids, and thus is expected to decrease the number of 
contact sites by reducing negative curvature of the inner mitochondrial membrane; 
perhaps by causing such effect, LCA may shift the equilibrium of membrane curvature 
towards the enhancement of cristae formation by promoting positive curvature of the 
inner mitochondrial membrane (Figure 2.13). Furthermore, LCA reduces the level of the 
cone-shaped species of PE enriched in unsaturated fatty acids, and thus is expected to 
decrease the number of contact sites by reducing negative curvature of the inner 
mitochondrial membrane (Figure 2.14). Moreover, LCA increases the level of the 
inverted cone-shaped species of PS enriched in saturated fatty acids and, thus, is expected 
 














Figure 2.13. LCA reduces the level of the cone-shaped species of CL enriched in unsaturated fatty acids, 
and thus is expected to decrease the number of contact sites by reducing negative curvature of the inner 
mitochondrial membrane; perhaps by causing such effect, LCA may shift the equilibrium of membrane 




Taken together, these findings suggest that, by enhancing the ability of the inner 
mitochondrial membrane to form cristae, LCA may alter the dynamics of mitochondrial 
respiration, electrochemical membrane potential maintenance and ROS production; 








Figure 2.14. LCA reduces the level of the cone-shaped species of PE enriched in unsaturated fatty acids, 





be responsible for the observed longevity extension by LCA. Recent findings by other 
graduate students in our laboratory support this assumption by demonstrating that LCA 
(1) causes profound changes in the size and number of mitochondria as well as in the 
length and morphology of mitochondrial cristae in WT cells grown under CR conditions; 
and (2) alters the age-related dynamics of several longevity-defining processes confined 







Figure 2.15. LCA elevates the level of the inverted cone-shaped species of PS enriched in saturated fatty 






Findings described in this chapter of my thesis strongly suggest that LCA extends 
longevity of chronologically aging yeast cultured under CR conditions in part by altering 
the composition of mitochondrial membrane lipids. Indeed, LCA causes the remodeling 
of the mitochondrial membrane by proportionally reducing the quantities of PE and CL 






such LCA-driven remodeling of the repertoire of mitochondrial membrane lipids is due to 
an inhibiting effect of LCA on the Crd1p- and Psd1p-driven reactions of the biosynthesis 
of CL and PE (respectively) in the inner mitochondrial membrane. LCA not only alters 
the total levels of CL, PE and PS in the mitochondrial membrane, but also has a specific 
effect in the relative abundance of their various molecular forms that differ from each 
other by the extent of saturation of the hydrophobic tails and their length. Indeed, we 
found that LCA (1) reduces the concentrations of the cone-shaped species of CL and PE 
enriched in unsaturated fatty acids, thereby shifting the equilibrium of membrane 
curvature towards the enhancement of cristae formation by promoting positive curvature 
of the inner mitochondrial membrane and (2) elevates the concentration of the inverted 
cone-shaped species of PS enriched in saturated fatty acids, thereby enhancing cristae 
formation by promoting positive curvature of the inner mitochondrial membrane. As 
other graduate students in our laboratory demonstrated, such LCA-driven remodeling of 
differently shaped molecular forms of PE, CL and PS reduces the number of 
mitochondria and increases their size. One could assume that the observed effect of LCA 
on the abundance of mitochondria is caused by the ability of this bile acid to shift a 
balance between the opposing processes of mitochondrial fission and fusion towards 
fusion, thereby preventing the fragmentation of mitochondria and the resulting efflux of 
cytochrome c and several other pro-apoptotic proteins from the mitochondrial 
intermembrane space. Ultimately, such effect of LCA on mitochondrial morphology may 
cause a delay of the age-related form of mitochondria-controlled apoptosis and longevity 
extension. Another likely outcome of the observed LCA-driven remodeling of differently 
 







mitochondrial inner membrane, which could be manifested in a great increase of the 
length of mitochondrial cristae and in a change of their morphology. This prediction has 
been recently confirmed by other graduate students in our laboratory. It is plausible that 
such LCA-driven enhancement of the ability of the mitochondrial inner membrane to 
form cristae is responsible for the observed proficiency of LCA in altering the age-related 
dynamics of changes in several longevity-defining processes confined to mitochondria, 






Findings described here imply that LCA extends longevity of chronologically aging yeast 
by (1) elevating the level of PS (a precursor for the synthesis of PE in mitochondria) in 
the mitochondrial membrane, thereby enhancing its positive effect on longevity-defining 
processes in this membrane; (2) reducing the level of PE in the mitochondrial membrane, 
thereby weakening its negative effect on longevity-defining processes in this membrane; 
and (3) proportionally decreasing the levels of PE and CL in the mitochondrial 
membrane, thereby increasing PS/CL and PS/PE ratios but maintaining PE/CL ratio of 
mitochondrial membrane lipids and causing some longevity-extending changes in this 
membrane. These LCA-induced alterations in mitochondrial membrane lipids can 
satisfactorily explain the important implications of LCA treatment on mitochondrial 
structure and function, including (1) the ability of LCA to cause dramatic changes in the 
length and curvature of the inner mitochondrial membrane; and (2) the ability of LCA to 













































































3 By altering mitochondrial membrane lipidome, lithocholic acid (LCA) 
 







Based on our findings described in Chapter 2 of my thesis and data of other researchers 
working in the field of mitochondrial biology, we hypothesized that, by altering the level 
of CL and other glycerophospholipids within the mitochondrial membrane, LCA could 
modulate the stoichiometry, composition and/or functional state of respiratory 
supercomplexes (respirasomes) in the inner mitochondrial membrane. To test the validity 
of this hypothesis, in studies described in this Chapter of my thesis we used a multistep 
method for recovery of intact respiratory complexes and supercomplexes from purified 
yeast mitochondria, their subsequent first-dimension electrophoretic separation using so- 
called blue-native gel electrophoresis (BN-PAGE), their resolution into individual protein 
components with the help of denaturing Tricine-SDS-PAGE, and the mass spectrometry 
(MS)-based identification of each of these individual protein components. Findings 
described in this chapter of my thesis validate our hypothesis. Specifically, these findings 
revealed several ways of rearranging respiratory supercomplexes in the inner 
mitochondrial membrane of cells exhibiting altered mitochondrial membrane lipidome in 
response to LCA treatment or genetic manipulations impairing the synthesis of CL and 
other glycerophospholipids within the inner membrane of mitochondria. First, by altering 
the level of CL and other glycerophospholipids synthesized and residing in the inner 
mitochondrial membrane, LCA modulates the abundance of several major respiratory 







manipulations-driven changes in the inner mitochondrial membrane lipidome cause a 
recruitment of a number of new mitochondrial protein components, not previously known 
for being permanently associated with the ETC, into the remodeled respirasomes. 
Importantly, many of the proteins newly recruited into the remodeled respirasomes are 






A growing body of evidence supports the view that the electron transport chain (ETC) in 
the inner mitochondrial membrane plays a pivotal role in regulating longevity of 
evolutionarily distant organisms by defining the efficacy of oxidative phosphorylation, 
electrochemical potential, ATP synthesis and reactive oxygen species (ROS) production 
in mitochondria as well as by modulating mitochondrial retrograde signaling and 
mitochondria-specific unfolded protein response [25, 51 - 58, 182, 238 - 241]. Two 
models have been proposed for the organization of the mitochondrial ETC. One of these 
models, known as the random diffusion model or the fluid model, suggests that 
respiratory complexes move in a random fashion within the inner mitochondrial 
membrane [242]. Another model, which is currently accepted by most researchers in the 
field of mitochondrial bioenergetics, is known as the solid model. This model suggests 
that the respiratory complexes are assembled into larger supercomplexes within the inner 
mitochondrial membrane; these larger supramolecular structures are also called 
respirasomes [243 - 252]. Several important advantages of the supramolecular 
organization of respiratory complexes into supercomplexes have been proposed, 







intermediates [243, 245 - 249, 252]. Substrate channeling is an efficient and beneficial 
process because it guides various intermediates of a biochemical process from one 
enzyme to another specific enzyme, thereby protecting every intermediate from being 
trapped by other enzymes; a body of evidence implies that this advantage is applicable to 
a mobile form of cytochrome c in yeast, bacterial and mammalian ETCs [243, 247, 248, 
251]. Thus, a supramolecular arrangement of individual respiratory complexes into 
supercomplexes/respirasomes enables a substantial catalytic enhancement of the ETC in 
the inner mitochondrial membrane [243 - 252]. Based on findings described in Chapter 2 
of this thesis, we concluded that under CR conditions LCA extends yeast longevity by 
remodeling the repertoire of mitochondrial membrane lipids and thereby modulating 
longevity-defining processes confined to and governed by mitochondria. Specifically, our 
findings presented in Chapter 2 of this thesis imply that LCA extends longevity of WT 
yeast by (1) elevating the level of PS (a precursor for the synthesis of PE in 
mitochondria) in the mitochondrial membrane, thereby enhancing its positive effect on 
longevity-defining processes in this membrane; (2) reducing the level of PE in the 
mitochondrial membrane, thereby weakening its negative effect on longevity-defining 
processes in this membrane; and (3) proportionally decreasing the levels of PE and CL in 
the mitochondrial membrane, thereby increasing PS/CL and PS/PE ratios but maintaining 
PE/CL ratio of mitochondrial membrane lipids and causing some longevity-extending 
changes in this membrane. It is important to emphasize that various molecular species of 
CL are known to control a number of vital mitochondria-confined processes by: (1) being 
associated with all five complexes of the mitochondrial respiratory chain, modulating 







respiratory supercomplexes or respirasomes; (2) binding to and modulating the activity of 
cytochrome c, a heme-containing mobile component of the mitochondrial respiratory 
chain also known for its essential role in mitochondria-controlled apoptosis; (3) being 
associated with and regulating adenine nucleotide translocator activity; (4) playing an 
important role in maintaining the electrochemical gradient across the inner mitochondrial 
membrane; (5) conferring fluidity and stability to the inner membrane of mitochondria; 
(6) being primary targets of ROS-inflicted damage because of their highly unsaturated 
acyl chains; and (7) regulating protein import into mitochondria [223 - 230]. Because of 
its propensity to associate via non-covalent interactions with numerous unrelated proteins 
in the inner mitochondrial membrane, CL (likely in collaboration with PE) acts as a 
molecular chaperone that governs the assembly of a number of protein assemblies 
involved in wide spectrum of essential biological processes [224 - 230]. 
Based on all these findings, we hypothesized that, by altering the level of CL and 
other glycerophospholipids within the mitochondrial membrane, LCA could modulate the 
stoichiometry, composition and/or functional state of respiratory supercomplexes 
(respirasomes) in the inner mitochondrial membrane. In our hypothesis, such LCA- and 
CL-dependent remodeling of the mitochondrial respiratory supercomplexes (1) may rely 
on a distinct set of protein components of the respiratory complexes that compose the 
respirasomes; (2) may recruit new mitochondrial protein components, not previously 
known for being permanently associated with the ETC, into the remodeled respirasomes; 
(3) may alter the age-dependent dynamics of mitochondrial respiration, oxidative 
phosphorylation, ADP/ATP exchange, ATP synthesis, membrane potential and/or ROS 







increasing the efficiency of ATP synthesis in chronologically aging yeast, altering the 
age-dependent dynamics of changes in mitochondrially produced ROS (thereby 
protecting yeast from chronic oxidative stress), and/or modulating the longevity-defining 
processes that in mitochondria are governed by proteins newly recruited into the 
remodeled respirasomes (even although some or all of these newly recruited proteins 
have not been traditionally viewed as proteins permanently associated with the ETC). 
To test the validity of this hypothesis, in studies described in this Chapter of my 
thesis we used a multistep method [243 - 253] for recovery of intact respiratory 
complexes and supercomplexes from purified yeast mitochondria, their subsequent first- 
dimension electrophoretic separation using so-called blue-native gel electrophoresis (BN- 
PAGE), their resolution into individual protein components with the help of denaturing 
Tricine-SDS-PAGE, and the mass spectrometry (MS)-based identification of each of 
these individual protein components. To do this, we first purified mitochondria by 
separating them from other cellular organelles. We then quantified the protein in each 
sample of highly purified mitochondria. These samples were fractionated in the first 
dimension with the help of BN-PAGE, a method known for its propensity in recovering 
intact mitochondrial respiratory complexes and supercomplexes ranging in their 
molecular weights from 10 kDa to 10 MDa [243 - 253]. The supercomplexes were then 
fractionated in the second dimension using denaturing Tricine-SDS-PAGE to yield 
individual protein components of various respiratory complexes and supercomplexes; the 
high-ionic strength Tricine-SDS gel was used for this purpose instead of a traditional 
SDS gel to ensure high protein recovery during electrophoretic run, which yields sharp 
 







of the gel, washed and digested with trypsin into individual peptides. The peptides were 
then analyzed using MS to identify all of the protein constituents of each of the isolated 




3.3 Materials and Methods 
 
Strains and media 
 
The wild-type strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 lys20 
ura30) and mutant strains ups1 (MAT his31 leu20 lys20 ura30 
ups1::kanMX4), taz1 (MAT his31 leu20 lys20 ura30 taz1::kanMX4), gep4 
(MAT his31 leu20 lys20 ura30 gep4::kanMX4), psd1 (MAT his31 leu20 
lys20 ura30 psd1::kanMX4) and crd1 (MAT his31 leu20 lys20 ura30 
crd1::kanMX4) were used in this study. Yeast were cultured in in YP medium (1% 
yeast extract, 2% peptone) initially containing 0.2% glucose as carbon source. The stock 
solution of LCA in DMSO or water (as indicated in the text) was made on the day of 
adding this compound to cell cultures. LCA was added to growth medium in DMSO or 
water (as indicated in the text) at the final concentration of 50 µM immediately following 
cell inoculation into the medium. The final concentration of DMSO in yeast cultures 
supplemented with LCA (and in the corresponding control cultures supplemented with 
drug vehicle) was 1% (v/v). Cells were cultured at 30
o
C with rotational shaking at 200 












1. Dithiothreitol (DTT) buffer [100 mM Tris-H2SO4, 10 mM dithiothreitol] 
 
2. Zymolyase 100T from Arthrobacter luteus (MP Biomedicals) 
 
3. Zymolyase buffer [1.2 M sorbitol, 20 mM potassium phosphate] 
 
4. Homogenization buffer [0.6 M sorbitol, 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 0.2% 
(w/v) BSA] 







Cell cultures were combined in pre-weighed centrifuge bottles and cells were pelleted at 
 
3,000 × g for 5 min at room temperature using a Beckman JA-10 rotor. The cells were 
washed twice with distilled water, followed by the determination of their wet weight. The 
cell pellets were resuspended in 2 ml/g DTT buffer and incubated on a shaker at 80 rpm 
for 20 min at 30ºC. The cells were pelleted as per initial centrifugation, washed in 7 ml/g 
Zymolyase buffer without Zymolyase and pelleted once more. The cells were incubated 
on a shaker at 80 rpm for 45 min at 30ºC with 1 mg/g (wet weight) of Zymolyase-100T in 
 
7 ml/g Zymolyase buffer. Zymolyase was used because of its well-known strong lytic 
activity required to digest yeast cell wall. The spheroplasts obtained were then spun down 
at 2,200 × g for 8 min at 4ºC. All subsequent steps were carried out on ice or at 4°C with 
the use of cut pipette tips to avoid breaking organelles. The spheroplasts were 
resuspended in 6.5 ml/g ice-cold homogenization buffer and washed by centrifugation at 
 
2,200 × g for 8 min at 4ºC. The spheroplasts were then mechanically homogenized with 
15 strokes in 6.5 ml/g ice-cold homogenization buffer to disrupt yeast plasma membrane 







was pelleted by centrifuging at 1,500 × g for 5 min at 4ºC using a Beckman JA-17 rotor. 
The resulting lysate supernatant was subjected to centrifugation twice at 3000 × g for 5 
min at 4ºC to pellet the nuclei and 12,000 × g for 15 min at 4ºC. The newly obtained 
pellet contains mostly mitochondria, but also the endoplasmic reticulum (ER), Golgi, 
peroxisomes, lysosomes and vacuoles, whereas the supernatant contains the cytosol, 
microsomes from the ER and vacuoles. The pellet was resuspended in 6.5 ml/g in ice- 
cold homogenizing buffer, spun down for 5 min at 3,000 × g at 4ºC to obtain a 
supernatant containing mitochondria, which was then subjected to a spin at 12, 000 × g 
for 15 min at 4ºC. The resulting pellet was resuspended in 3 ml of SEM to be overlaid 








1. SEM buffer [250 mM sucrose, 1 mM EDTA, 10 mM Mops (pH 7.2)] 
 






In order to purify yeast mitochondria from the crude mitochondrial fraction, an 
equilibrium density-gradient centrifugation was performed. Yeast mitochondria have a 
density of 1.18 g/cm
3  





. To prepare a sucrose density gradient for the purification of 






of 23% and 1.5 ml of 15% sucrose in EM buffer, followed by 3 ml of the crude 
mitochondrial suspension. The sucrose density gradient containing the mitochondrial 
suspension was subjected to centrifugation in a Beckman SW41 Ti swinging-bucket rotor 
at 134,000 × g for 60 min at 4ºC.  The mitochondrial band, which was easily 
distinguishable, appeared at the interface between 60% and 32% sucrose. Fractions of 1 
ml were recovered using a cut pipette tip and placed in 1.5 ml Eppendorf tubes and 
frozen at -80ºC until use. In order to quickly freeze the mitochondrial fractions, the 
fractions were immersed, with the aid of long tweezers, in a beaker of isopropyl alcohol 








1. Hoefer SE 400 vertical slab gel electrophoresis unit 
 







1. 4% acrylamide running gel [1.5 ml AB (acrylamide/bis-acrylamide)-3 mix, 6 ml gel 
buffer 3×, 10.4 ml distilled water, 100 l APS, 10 l TEMED] 
2. 13% acrylamide running gel 
 
3. 3.5% acrylamide sample gel 
 
4. Solubilization buffer A [50 mM sodium chloride, 50 mM imidazole/HCl, 2 mM 6- 
aminohexanoic acid, 1 mM EDTA, pH 7.0] 







6. Cathode buffer B [50 mM Tricine, 7.5 mM imidazole, 0.02% Coomassie blue G-250, 
pH 7.0] 
7. Cathode buffer B/10 [50 mM Tricine, 7.5 mM imidazole, 0.002% Coomassie blue G- 
 
250, pH 7.0] 
 







Mitochondria protein aliquots of 400 g were pelleted by centrifugation at 50,000 × g for 
 
30 min using a Beckman MLS-50 rotor. The mitochondria pellet was resuspended in 40 
 
l of solubilization buffer A and the mitochondria membranes were homogenized by 
twirling a tiny spatula. The detergent digitonin at 20% (3.0 g/g; i.e., 6l) was added to the 
homogenate, which was incubated for 10 min at room temperature. The sample was 
subsequently centrifuged at 20,000 × g for 20 min at room temperature. To the resulting 
supernatant, 5 l of 5% Coomassie blue G-250 dye in 50% glycerol was added at an 8 
g/g detergent/dye ratio (i.e., 3 l). The sample containing solubilized mitochondrial 
membrane was loaded to a 0.16 × 0.5 cm well of a gradient separation gel with 
dimensions 1.5 × 14 × 15 cm composed of 4% and 13% acrylamide mixture with a 
sample gel of 3.5% acrylamide. Urease at 1mg/ml was also loaded on an adjacent well 
and used as a molecular marker (10 l urease, 10 l buffer A, 2.4 l 50 % glycerol, 1.6 l 
 
5% Coomassie blue G-250). BN-PAGE was performed at 4°C under the following 
conditions: 300 ml of Cathode buffer B in the upper chamber and 300 ml of Anode buffer 
in the lower chamber were used and the power supply set at constant 100 V, 15 mA, 400 






and 15 mA until the blue running front moved about a third of the total running distance. 
At this point, Cathode Buffer B was replaced with 300 ml of Cathode buffer B/10 for 
better detection of faint protein bands and electrophoresis was continued for a total of 4 h 
or until the blue running front was 1 cm from the bottom of the gel. Once electrophoresis 
was completed the blue native gel stained with Coomassie blue G-250 was photographed, 








1. Hoefer SE 400 vertical slab gel electrophoresis unit 
 







1. 10%T, 3%C Tricine-SDS running gel 
 
2. 10% acrylamide native stacking gel 
 
3. Anode buffer 10× [1.0 M Tris, 0.225 M HCl, pH 8.9] 
 
4. Cathode buffer 10× [1.0 M Tris, 1.0 M Tricine, 1% SDS, pH 8.25] 
 






A 0.5-cm gel strip was cut from the 1
st  
dimension (1D) BN-PAGE gel and placed on a 
glass plate with the top of the strip to the left and the bottom of the strip to the right. The 






2 h at room temperature. Following the incubation, the strip was thoroughly rinsed with 
water and squeezed in between 1.5-mm spacers and 18 × 16 cm glass plates. A 30-ml 
separating gel mixture composed of 10%T, 3%C Tricine-SDS was poured in between the 
glass plates leaving a gap of 0.5 cm from the native gel strip. After polymerization, a 0.5- 
cm spacer was inserted between the plates, and placed to the right of the gel to create a 
well to load protein markers. In order to fill the 0.5-cm gap between the running gel and 
the native strip, as well as the space between the native gel and the spacers, 5 ml of a 
10% acrylamide native gel mixture was used, and Unstained protein molecular markers 
(Bio-Rad) were loaded to the far right of the gel for reference. Electrophoresis was 




Silver stain after 1D-BN-PAGE followed by 2D-Tricine-SDS-PAGE 
 









1. Fixative solution [200 ml methanol, 40 ml acetic acid, 40 ml Fixative Enhancer 
solution, 120 ml distilled water] 
2. Staining solution [35 ml distilled water, 5 ml Silver complex solution, 5 ml Reduction 
Moderator solution, 5 ml Image Development solution, 50 ml Development Accelerator 
solution] 












Once electrophoresis was completed, the gel was incubated in 400 ml of 50% methanol 
on a shaker at 55 rpm for 2 h. The gel was then incubated in 200 ml of the Fixative 
solution for 20 min and washed twice with 200 ml of distilled water for 10 min. The gel 
was then immersed in 100 ml of the Staining Solution composed of Silver complex, 
Reduction Moderator, Image Development and Development Accelerator solutions. Once 
the desired staining intensity was reached, development was immediately stopped by 
incubating the silver stained gel in 400 ml of 5% acetic acid for 15 min, which was 
followed by a rinse with 400 ml of distilled water for 5 min. The gel was then 








1. 30 mM Potassium Ferricyanide 
 
2. 100 mM Sodium Thiosulfate 
 
3. 100mM Ammonium Bicarbonate (ABC) 
 
4. 10 mM Dithiothreitol (DTT) [in 5ml of 100mM Ammonium Bicarbonate (ABC)] 
 
5. 55 mM Iodoacetamide (IAA) [in 5ml of 100mM Ammonium Bicarbonate (ABC)] 
 






Once the individual mitochondrial proteins were separated, each band on the 1D BN-2D 






siliconized Eppendorf tubes. The bands were washed with distilled water and destained 
with 50 l of a 1:1 mixture of 20 mM potassium ferricyanide and 100 mM sodium 
thiosulfate for 20 min in the dark with occasional vortexing. The destaining solution was 
removed and the bands were washed twice with distilled water. The bands were then 
incubated in 50 l of acetonitrile (ACN) for 5 min at 37°C, after which ACN was 
removed and the bands were dried at 37°C. Next, the destained bands were incubated in 
50 l of 10 mM dithiothreitol for 30 min at 37°C to reduce thiol groups in peptides. DTT 
was discarded and the bands were incubated in 50 l of 55 mM iodoacetamide for 20 min 
at 37°C in the dark to remove the residual DTT. IAA was removed and the bands were 
incubated in 50 l of a 1:1 mixture of 100 mM ABC and 50% acetonitrile for 10 min at 
37°C. The mixture was discarded and the bands were incubated twice in 50 l of CAN 
under the same conditions and dried at 37°C. The trypsin and trypsin buffer were 
prepared as follows: (1) 1.6 ml of a 1:1 mixture of 100 mM ABC and 10mM CaCl2  were 
used to resuspend 20 g of trypsin; and (2) for protein digest, 50 l of trypsin solution (1 




Extracting peptides from yeast mitochondrial proteins digested with trypsin 
 
The following day, the samples were spun down and the supernatants containing peptides 
were transferred to new 0.5-ml siliconized Eppendorf tubes. To extract more peptides, the 
gel pieces were subjected to several washes and treatments at room temperature; the 
supernatants were conserved and combined with the first set to extracted peptides. For the 
first extraction, the bands were initially incubated in 50 l of 25 mM ABC for 10 min and 





added to the first set of extracted peptides.  For the second extraction, the bands were 
incubated in 50 l of 5% formic acid for 10 min and then in 50 l of ACN for 10 min. 
The samples were spun down and the supernatant were combined with the first set of 
extracted peptides. The gel pieces were no longer used and discarded. To prevent 
possible oxidation during storage, 12.5 l of 100 mM DTT was added to each set of 
peptides. The peptides were completely dried in a Speed-Vac at medium temperature 




Sample preparation for MS analysis 
 
Dried peptides were resuspended in 20 l of 5% ACN. For each recovered protein band, 
an aliquot of 10 l of dried peptides in 5% ACN was diluted 2-fold in Nano pure water 






Individual proteins composing each band were then identified by reverse phase high 
performance liquid chromatography coupled to mass spectrometry (RP-HPLC/MS) using 
an LTQ Orbitrap. 3-l aliquots of peptides were separated in ACN gradient using a 100- 





Analysis using the Thermo Proteome Discoverer application and SEQUEST 
Once acquiring time was completed using the LTQ Orbitrap, the raw mass spectrometry 
data file obtained by Xcalibur were analyzed using the Thermo Scientific Xcalibur 





Discoverer. The Proteome Discoverer was used to identify individual protein components 
of the isolated mitochondrial respiratory complexes and supercomplexes by comparing 
the raw data of mass spectra of digested fragments to the mass spectra of peptides within 
the Uniprot FASTA database. The analysis by the Proteome Discoverer coupled to the 
FASTA database was enabled by using the peak-finding search engine SEQUEST. The 
SEQUEST engine processes MS data using a peak-finding algorithm to search the raw 




SEQUEST search wizard within the Proteome Discoverer application 
 
Raw file and Scan Range Selection Parameters 
 
The raw file was selected and the Base peak ion chromatogram appeared to reveal: (1) 
 
the “Intensity (counts)” corresponding to the intensity of the largest peak in the spectrum; 
and (2) the “Time (min)” showing the retention time (RT). The following algorithm and 




Lower RT Limit (min) 
 





Upper RT Limit (min) 
 














The mass of the first precursor ion in the range of ion fragments to search for in the 






The mass of the last precursor ion in the range of ion fragments to search for in the 













Unrecognized charge replacement 
 
Specifies the charge number of the precursor ions: Automatic (Default), assigns a charge 






Specifies the intensity threshold below which ions are filtered out. The default value of 
 





Minimum ion count 
The minimum ion count corresponds to the minimum number of ions that must be present 











The signal-to-noise threshold is the intensity of the signal to the intensity of the 
background noise. The use of this threshold filters out low-intensity ions that function as 




















The maximum number of internal cleavage sites per peptide fragment that is acceptable 




Precursor mass tolerance 
 
The precursor mass tolerance value used for finding peptide candidates. The possible 




Fragment mass tolerance 
The default mass tolerance value of 0.8 Da was used for matching fragment peaks. The 









Ions series calculated 
 
Specifies the ion factors for a, b, c, x, y, and z ions for the experiment type. The possible 




Search against decoy database 
 





Target FDR (strict) 
 
Specifies a strict target false discovery rate (FDR) for peptide matches with high 
confidence. The possible value range of 0.0 to 1.0 was used. The default value of 0.01 




Target FDR (relaxed) 
 
Specifies a relaxed target false discovery rate (FDR) for peptide matches with moderate 
confidence. The possible value range from 0.0 to 1.0 was used. The default value of 0.05 




Identification of yeast mitochondria complexes and supercomplexes using the 
 
Thermo Proteome Search Results Report 
 















The protein page displays all the proteins and their corresponding peptides found in the 























The SEQUEST protein score is the sum of all peptide XCorr values above the specified 
score threshold. The score threshold was calculated as “0.8 + peptide charge * peptide 
relevance factor“, where peptide relevance factor has a default value of 0.4. For each 
spectrum, only the highest-scoring match was used. For each spectrum and sequence, the 





















Represents the number of identified proteins in the protein group of a master protein. 




# Unique Peptides 
 














The peptide spectrum matches (PSMs) value corresponds to the total number of identified 



















Represents the theoretically calculated isoelectric point, i.e. the pH value at which a 









Peptides Results Parameters 
 







Identifies a protein associated with the peptides. This description is taken from the 
 




























Scores the number of fragment ions that are common to two different peptides with the 
same precursor mass; calculates the cross-correlation score for all candidate peptides 














A measure of the difference between the top two scores for the peptides identified by that 
spectrum; the Proteome Discoverer application calculates this score as follows: ΔScore = 






Represents the normalized score difference between the currently selected PSM and the 




# Missed Cleavages 
 
Represents the number of cleavage sites in a peptide sequence that trypsin did not cleave, 







Represents the number of peptides included in the precursor mass tolerance window set 
































Represents the difference between the theoretical mass of the peptide and the 











Xcalibur is a registered trademark of Thermo Fisher Scientific Inc. in the United States. 







3.4.1 LCA and genetic manipulations changing the makeup of mitochondrial 
membrane lipids alter the abundance of respiratory supercomplexes in the 
inner mitochondrial membrane 
Based on our previous findings and data of other researchers working in the field of 
mitochondrial bioenergetics, we hypothesized that, by altering the level of CL and other 
glycerophospholipids within the mitochondrial membrane, LCA could modulate the 
abundance of some of the respiratory supercomplexes (respirasomes) in the inner 







hypothesis, we first used a method for recovery of intact respiratory complexes and 
supercomplexes from purified yeast mitochondria followed by their first-dimension 
electrophoretic separation using BN-PAGE [243 - 253]. Using this method, we assessed 
the relative abundance of respiratory supercomplexes in the inner membranes of 
mitochondria that were purified from cells of WT strain and cells of various long- and 
short-lived mutant strains impaired in different aspects of CL, PE and PS metabolism, 
either exposed to LCA or remained untreated. Cells of WT and mutant strains were 
cultured under CR conditions on 0.2% glucose, and mitochondria were purified from 
cells recovered at day 4 of culturing. We found that LCA and mutations changing the 
makeup of mitochondrial membrane lipids (see Chapter 2 of this thesis) alter the 
abundance of respiratory supercomplexes in the inner mitochondrial membrane (Figure 
3.1). 
 
Specifically, our BN-PAGE analysis revealed that exposure of WT cells to LCA 
significantly increases the level of a respiratory supercomplex with the highest molecular 
weight (likely in a range of several MDa), which is marked by a red arrow in Figure 3.1. 
Our MS-based analysis described below (see section 3.4.2 of this Chapter on my thesis) 
revealed that this respiratory supercomplex in the inner mitochondrial membrane of 
LCA-treated WT cells consists of (1) complexes II, III, IV and V of the mitochondrial 
ETC; (2) the ADP-ATP carrier protein (called AAC2 or ADT2); (3) the mitochondrial 
external NADH dehydrogenase NDE1, a type II NAD(P)H:quinone oxidoreductase that 
catalyzes the oxidation of cytosolic NADH to provide cytosolic NADH to the 
mitochondrial ETC; and (4) the mitochondrial protein MMF1 that is required for 









Figure 3.1. LCA and genetic manipulations changing the composition of mitochondrial membrane lipids 
alter the abundance of respiratory supercomplexes in the inner mitochondrial membrane. Cells of WT 
strain, as well as cells of various long- and short-lived mutant strains impaired in different aspects of CL, 
PE and PS metabolism, were grown in YP medium initially containing 0.2% glucose as carbon source, 
without LCA or with this bile acid (used in the concentration of 50 μM). Cells were collected for the 
purification of mitochondria at day 4. The purification of mitochondria, solubilization of native respiratory 
supercomplexes and their first-dimension BN-PAGE separation were performed as described in Materials 









Bat1p and Bat2p, and is known to interact genetically with mitochondrial ribosomal 
protein genes. 
Our BN-PAGE analysis also demonstrated that exposure of WT cells to LCA 
increases the level of a respiratory supercomplex of a very high molecular weight (likely 
in an MDa range), which is marked by a yellow arrow in Figure 3.1. Our MS-based 
analysis described below (see section 3.4.2 of this Chapter on my thesis) showed that this 
respiratory supercomplex in the inner mitochondrial membrane of LCA-treated WT cells 
consists of (1) complexes III and V of the mitochondrial ETC; (2) the ALD4 isoform of 
acetaldehyde dehydrogenase, an enzyme involved in the conversion of acetaldehyde to 
acetyl-CoA in yeast mitochondria; (3) the IDH1 and IDH2 isoforms of isocitrate 
dehydrogenase, an enzyme involved in the TCA cycle; and (4) the mitochondrial porin 
POR1, a voltage-dependent anion channel required for the maintenance of mitochondrial 
osmotic stability and mitochondrial membrane permeability. 
We found that each of the tested mutations impairing different aspects of CL, PE 
and PS metabolism in the inner mitochondrial membrane affects the abundance of one or 
more respiratory supercomplexes in this membrane. Such effects of these mutations were 
observed in cells exposed to LCA or remained untreated, as described below. 
In cells not exposed to LCA, the gep4Δ mutation (known to impair the synthesis of 
phosphatidylglycerol from phosphatidylglycerol phosphate [see Figure 2.1] and to 
shorten yeast longevity [Beach et al., manuscript in preparation]) significantly increases 
the level of a respiratory supercomplex with the highest molecular weight (likely in a 
range of several MDa), which is marked by a red arrow in Figure 3.1. Our MS-based 







respiratory supercomplex in the inner mitochondrial membrane of gep4Δ cells not 
exposed to LCA consists of (1) complex V of the mitochondrial ETC; (2) the 
mitochondrial external NADH dehydrogenase NDE1, a type II NAD(P)H:quinone 
oxidoreductase that catalyzes the oxidation of cytosolic NADH to provide cytosolic 
NADH to the mitochondrial ETC; (3) the mitochondrial succinate-fumarate transporter 
SFC1, which is known to transport succinate into and fumarate out of the mitochondrion 
and to be required for ethanol and acetate utilization; (4) the lipid-binding protein PIL1, a 
mitochondrial member of the BAR domain protein family; and (5) the mitochondrial 
porin POR1, a voltage-dependent anion channel required for the maintenance of 
mitochondrial osmotic stability and mitochondrial membrane permeability. 
Furthermore, in cells not exposed to LCA, the gep4Δ mutation also increases the 
level of a respiratory supercomplex of a very high molecular weight (likely in an MDa 
range), which is marked by a yellow arrow in Figure 3.1. Our MS-based analysis 
described below (see section 3.4.2 of this Chapter on my thesis) showed that this 
respiratory supercomplex in the inner mitochondrial membrane of gep4Δ cells not 
exposed to LCA consists of (1) complexes III and V of the mitochondrial ETC; (2) the 
IDH1 and IDH2 isoforms of isocitrate dehydrogenase, an enzyme involved in the TCA 
cycle; and (3) the ADP-ATP carrier protein AAC2. 
Moreover, in cells not exposed to LCA, the gep4Δ mutation greatly reduces the 
levels of two high-molecular-weight (both likely in an MDa range) respiratory 
supercomplexes that are marked by blue and green arrows in Figure 3.1. 
Of note, an exposure of gep4Δ cells to LCA, reduces (not elevates, as in LCA- 
 







(likely in an MDa range), which is marked by a yellow arrow in Figure 3.1. Our MS- 
based analysis described below (see section 3.4.2 of this Chapter on my thesis) revealed 
that this respiratory supercomplex in the inner mitochondrial membrane of LCA-treated 
WT cells consists of (1) complexes III and V of the mitochondrial ETC; (2) the ALD4 
isoform of acetaldehyde dehydrogenase, an enzyme involved in the conversion of 
acetaldehyde to acetyl-CoA in yeast mitochondria; (3) the IDH1 and IDH2 isoforms of 
isocitrate dehydrogenase, an enzyme involved in the TCA cycle; and (4) the 
mitochondrial porin POR1, a voltage-dependent anion channel required for the 
maintenance of mitochondrial osmotic stability and mitochondrial membrane 
permeability. 
We also found that in cells not exposed to LCA, the crd1Δ mutation (known to 
impair the synthesis of CL from PG [see Figure 2.1] and to shorten yeast longevity 
[Beach et al., manuscript in preparation]) greatly reduces the levels of two high- 
molecular-weight (both likely in an MDa range) respiratory supercomplexes that are 
marked by blue and green arrows in Figure 3.1. This effect of the crd1Δ mutation was 
reminiscent to the changes in the abundance of these two respiratory supercomplexes 
seen in gep4Δ mutant cells not exposed to LCA (Figure 3.1). Furthermore, the crd1Δ 
mutation impairs the observed in LCA-treated WT cells rise in the levels of two 
rrespiratory supercomplexes marked by red and yellow arrows in Figure 3.1. 
Notably, although in the absence of LCA the taz1Δ mutation (known to impair the 
conversion of CL to MLCL [see Figure 2.1] and not to affect yeast longevity [Beach et 
al., manuscript in preparation]) does not alter the abundance of any respiratory 







this mutation greatly reduces the levels of three high-molecular-weight respiratory 
supercomplexes that are marked by red, blue and green arrows in Figure 3.1. It should be 
emphasized that, as we found, the taz1Δ mutation eliminates the longevity-extending 
effect of LCA (Beach et al., manuscript in preparation). 
Noteworthy, in the absence of LCA the psd1Δ mutation (known to impair the 
conversion of PS to PE [see Figure 2.1] and to significantly shorten yeast longevity 
[Beach et al., manuscript in preparation]) entirely abrogates the assembly of all of the 
respiratory supercomplexes found in WT cells not exposed to LCA (Figure 3.1). 
However, an exposure of psd1Δ mutant cells to LCA (1) suppresses the caused by the 
psd1Δ mutation defect in the assembly of each of these respiratory supercomplexes; and 
(2) just like in LCA-treated WT cells, increases the levels of two high-molecular-weight 
respiratory supercomplexes that are marked by red and yellow arrows in Figure 3.1. It 
should be emphasized that, as we found, the psd1Δ mutation enhances the longevity- 
extending efficacy of LCA (Beach et al., manuscript in preparation). 
Finally, in cells not exposed to LCA, the ups1Δ mutation (known to eliminate a 
mitochondrial membrane protein that stimulates the synthesis of CL and inhibits the 
synthesis of PE [see Figure 2.1] and to shorten yeast longevity [Beach et al., manuscript 
in preparation]) greatly reduces the levels of two high-molecular-weight (both likely in an 
MDa range) respiratory supercomplexes that are marked by blue and green arrows in 
Figure 3.1. This effect of the ups1Δ mutation was reminiscent to the changes in the 
abundance of these two respiratory supercomplexes seen in gep4Δ and crd1Δ mutant cells 
not exposed to LCA (Figure 3.1). Furthermore, the ups1Δ mutation impairs the observed 












3.4.2 In WT cells, LCA alters the composition of several respiratory and non- 
respiratory protein supercomplexes in the inner mitochondrial membrane 
In our hypothesis, by altering the level of CL and other glycerophospholipids within the 
mitochondrial membrane in WT cells, LCA could modulate not only the abundance of 
some of the respiratory supercomplexes (respirasomes) in the inner mitochondrial 
membrane, but also their protein composition (see section 3.2 of this thesis). According 
to our hypothesis, such LCA-dependent remodeling of the mitochondrial respiratory 
supercomplexes in WT cells may recruit new mitochondrial protein components, not 
previously known for being permanently associated with the ETC, into the remodeled 
respirasomes. We also hypothesized that LCA may alter the composition of some non- 
respiratory protein supercomplexes in the inner mitochondrial membrane or stimulate 
their de novo formation. To test the validity of this hypothesis, we used a multistep 
method [243 - 253] for recovery of intact respiratory complexes and supercomplexes 
from purified yeast mitochondria, their subsequent first-dimension electrophoretic 
separation using BN-PAGE, their resolution into individual protein components with the 
help of denaturing Tricine-SDS-PAGE, and the MS-based identification of each of these 
individual protein components. Cells of WT strain were cultured under CR conditions on 
0.2% glucose, and mitochondria were purified from cells recovered at day 4 of culturing. 
We found that LCA alters the composition of several respiratory and non-respiratory 
protein supercomplexes in the inner mitochondrial membrane (Figures 3.2 and 3.3). 








Figure 3.2. The composition of respiratory and non-respiratory protein supercomplexes in the inner 
mitochondrial membrane of WT cells not exposed to LCA. Respiratory and non-respiratory protein 
supercomplexes recovered using a first-dimension BN-PAGE were dissociated into individual protein 
components with the help of a second-dimension Tricine-SDS-PAGE and identified using MS-based 
proteomics. Cells of WT strain were grown in YP medium initially containing 0.2% glucose as carbon 
source without LCA. Cells were collected for the purification of mitochondria at day 4. The purification of 
mitochondria, solubilization of native respiratory and non-respiratory protein supercomplexes, their first- 
dimension BN-PAGE separation, their resolution into individual protein components with the help of 
denaturing Tricine-SDS-PAGE, and the MS-based identification of each of these individual protein 
components were performed as described in Materials and Methods. 
 
 
one high-molecular-weight (likely in an MDa range) non-respiratory protein 
supercomplex, increases the molecular weight of a respiratory supercomplex, and 







Figure 3.3. In WT cells, LCA alters the composition of several respiratory and non-respiratory protein 
supercomplexes in the inner mitochondrial membrane. Respiratory and non-respiratory protein 
supercomplexes recovered using a first-dimension BN-PAGE were dissociated into individual protein 
components with the help of a second-dimension Tricine-SDS-PAGE and identified using MS-based 
proteomics. Cells of WT strain were grown in YP medium initially containing 0.2% glucose as carbon 
source in the presence of 50 μM LCA. Cells were collected for the purification of mitochondria at day 4. 
The purification of mitochondria, solubilization of native respiratory and non-respiratory protein 
supercomplexes, their first-dimension BN-PAGE separation, their resolution into individual protein 
components with the help of denaturing Tricine-SDS-PAGE, and the MS-based identification of each of 













and non-respiratory protein supercomplexes in the inner mitochondrial membrane of WT 
 
cells is presented below. 
 
LCA causes a remodeling of respiratory supercomplex 1 by: (1) promoting the 
incorporation of respiratory complex IV into this supercomplex; (2) stimulating the 
insertion of the mitochondrial protein MMF1 (which is required for transamination of 
isoleucine, may regulate specificity of branched-chain transaminases Bat1p and Bat2p, 
and is known to interact genetically with mitochondrial ribosomal protein genes) into this 
supercomplex; and (3) causing a release of PDA1 (an E1 alpha subunit of the pyruvate 
dehydrogenase complex, which catalyzes the direct oxidative decarboxylation of 
pyruvate to acetyl-CoA), PDB1 (an E1 alpha subunit of the pyruvate dehydrogenase 
complex, which catalyzes the direct oxidative decarboxylation of pyruvate to acetyl- 
CoA) and POR1 (a voltage-dependent anion channel, which is called porin and is 
required for the maintenance of mitochondrial osmotic stability and mitochondrial 
membrane permeability) from this supercomplex (Figures 3.2 and 3.3). 
LCA causes a remodeling of respiratory supercomplex 2 by causing a release of 
POR1 (porin, a voltage-dependent anion channel required for the maintenance of 
mitochondrial osmotic stability and mitochondrial membrane permeability) and AAC2 
(an ADP-ATP carrier protein) from this supercomplex (Figures 3.2 and 3.3). 
LCA causes a remodeling of respiratory supercomplex 3 by: (1) stimulating the 
insertion of ADH3 (a mitochondrial alcohol dehydrogenase isozyme III involved in the 
shuttling of mitochondrial NADH to the cytosol and ethanol production); and (2) causing 
a release of respiratory complex III from this supercomplex (Figures 3.2 and 3.3). 







formed by YME2 (an integral inner mitochondrial membrane protein with a role in 
maintaining mitochondrial nucleoid structure and number); this supercomplex is given 
number 4 in Figure 3.2. 
LCA increases the molecular weight of a respiratory supercomplex composed of 
respiratory complexes III, IV and V; this supercomplex is given number 5 in Figure 3.2 
and number 4 in Figure 3.3. 
Finally, LCA stimulates the formation of a high-molecular-weight non-respiratory 
protein supercomplex 7 that cannot be detected in WT cells not exposed to LCA (Figures 
3.2 and 3.3). This supercomplex consists of (1) AAC2, an ADP-ATP carrier protein; (2) 
the ALD4 isoform of acetaldehyde dehydrogenase, an enzyme involved in the conversion 
of acetaldehyde to acetyl-CoA in yeast mitochondria; and (3) the porin POR1, a voltage- 
dependent anion channel required for the maintenance of mitochondrial osmotic stability 




3.4.3 Genetic manipulations changing the makeup of mitochondrial membrane 
lipids alter the composition of respiratory supercomplexes in the inner 
mitochondrial membrane 
According to our hypothesis, genetic manipulations that alter the level of CL and other 
glycerophospholipids within the mitochondrial membrane could modulate not only the 
abundance of some of the respiratory supercomplexes (respirasomes) in the inner 
mitochondrial membrane, but also their protein composition (see section 3.2 of this 
thesis). We hypothesized that such remodeling of the mitochondrial respiratory 







previously known for being permanently associated with the ETC, into the remodeled 
respirasomes. We also assumed that genetic manipulations changing the makeup of 
mitochondrial membrane lipids may alter the composition of some non-respiratory 
protein supercomplexes in the inner mitochondrial membrane or stimulate their de novo 
formation. To test the validity of this hypothesis, we used a multistep method [243 - 253] 
for recovery of intact respiratory complexes and supercomplexes from purified yeast 
mitochondria, their subsequent first-dimension electrophoretic separation using BN- 
PAGE, their resolution into individual protein components with the help of denaturing 
Tricine-SDS-PAGE, and the MS-based identification of each of these individual protein 
components. Cells of the gep4Δ, crd1Δ and taz1Δ mutant strains were cultured under CR 
conditions on 0.2% glucose (with or without LCA), and mitochondria were purified from 
cells recovered at day 4 of culturing. We found that each of these mutations alters the 
composition of several respiratory and non-respiratory protein supercomplexes in the 
inner mitochondrial membrane, regardless of the presence of LCA (Figures 3.5 - 3.9). 
A detailed description of changes in the composition of respiratory and non- 
respiratory protein supercomplexes in the inner mitochondrial membrane of gep4Δ, 
crd1Δ and taz1Δ mutant cells, exposed to LCA or remained untreated, is presented below. 
 
In gep4Δ mutant cells not exposed to LCA, the respiratory supercomplex 1: (1) 
lacks respiratory complexes II and III of the ETC; (2) lacks AAC2, an ADP-ATP carrier 
protein; (3) lacks PDA1 (an E1 alpha subunit of the pyruvate dehydrogenase complex, 
which catalyzes the direct oxidative decarboxylation of pyruvate to acetyl-CoA) and 












Figure 3.4. The composition of respiratory and non-respiratory protein supercomplexes in the inner 
mitochondrial membrane of gep4Δ mutant cells not exposed to LCA. Respiratory and non-respiratory 
protein supercomplexes recovered using a first-dimension BN-PAGE were dissociated into individual 
protein components with the help of a second-dimension Tricine-SDS-PAGE and identified using MS- 
based proteomics. Cells of gep4Δ mutant strain were grown in YP medium initially containing 0.2% 
glucose as carbon source without LCA. Cells were collected for the purification of mitochondria at day 4. 
The purification of mitochondria, solubilization of native respiratory and non-respiratory protein 
supercomplexes, their first-dimension BN-PAGE separation, their resolution into individual protein 
components with the help of denaturing Tricine-SDS-PAGE, and the MS-based identification of each of 
these individual protein components were performed as described in Materials and Methods. 
 
 
direct oxidative decarboxylation of pyruvate to acetyl-CoA); (4) acquires the lipid- 
binding protein PIL1, a mitochondrial member of the BAR domain protein family; and 
(5) acquires the mitochondrial succinate-fumarate transporter SFC1, which is known to 




ethanol and acetate utilization (compare Figures 3.2 and 3.4). 
 
In gep4Δ mutant cells not exposed to LCA, the respiratory supercomplex 2: (1) 
lacks respiratory complexes III and V of the ETC; (2) lacks AAC2, an ADP-ATP carrier 
protein; (3) lacks the mitochondrial porin POR1, a voltage-dependent anion channel 
required for the maintenance of mitochondrial osmotic stability and mitochondrial 
membrane permeability; (4) acquires the mitochondrial succinate-fumarate transporter 
SFC1, which is known to transport succinate into and fumarate out of the mitochondrion 
and to be required for ethanol and acetate utilization; (5) acquires the lipid-binding 
protein PIL1, a mitochondrial member of the BAR domain protein family; and (6) 
acquires PDH1, a protein that participates in respiration through a mechanism that 
remains to be established (compare Figures 3.2 and 3.4). 
In gep4Δ mutant cells not exposed to LCA, the respiratory supercomplex 4: (1) 
acquires complexes III and V of the mitochondrial ETC; and (2) acquires INH1, a 
calmodulin-binding protein that inhibits ATP hydrolysis by respiratory complex V 
(compare Figures 3.2 and 3.4). 
Importantly, gep4Δ mutant cells not exposed to LCA lack a respiratory 
supercomplex that in untreated with LCA WT cells is called respiratory supercomplex 5 
and consists of respiratory complexes III, IV and V (compare Figures 3.2 and 3.4). 
In gep4Δ mutant cells not exposed to LCA, the respiratory supercomplex 5: (1) 
lacks the ALD4 isoform of acetaldehyde dehydrogenase, an enzyme involved in the 
conversion of acetaldehyde to acetyl-CoA in yeast mitochondria; (2) lacks the 
mitochondrial porin POR1, a voltage-dependent anion channel required for the 







permeability; and (3) acquires AAC2, an ADP-ATP carrier protein (compare Figures 3.2 
and 3.4). 
In gep4Δ mutant cells treated with LCA, the respiratory supercomplex 1: (1) lacks 
respiratory complexes II and IV; (2) lacks the mitochondrial external NADH 
dehydrogenase NDE1, a type II NAD(P)H:quinone oxidoreductase that catalyzes the 
oxidation of cytosolic NADH to provide cytosolic NADH to the mitochondrial ETC; (3) 
lacks the mitochondrial protein MMF1 (which is required for transamination of 
isoleucine, may regulate specificity of branched-chain transaminases Bat1p and Bat2p, 
and is known to interact genetically with mitochondrial ribosomal protein genes) into this 
supercomplex; (4) acquires citrate synthase CIT1, a rate-limiting enzyme of the TCA 
cycle which catalyzes the condensation of acetyl coenzyme A and oxaloacetate to form 
citrate; (5) acquires aconitase ACO1, which is required for the TCA cycle and also 
independently required for mitochondrial genome maintenance; (6) acquires PDH1, a 
protein that participates in respiration through a mechanism that remains to be 
established; (7) acquires PRX1, a mitochondrial peroxiredoxin with thioredoxin 
peroxidase activity; (8) acquires SOD2, a mitochondrial manganese superoxide dismutase 
that protects cells against extremely toxic superoxide radicals; (9) acquires MIR1, a 
mitochondrial phosphate carrier that imports inorganic phosphate into mitochondria; (10) 
acquires the lipid-binding protein PIL1, a mitochondrial member of the BAR domain 
protein family; (11) acquires AIM46, a protein required for mitochondrial DNA 
maintenance; and (12) acquires FMP46, a protein protecting mitochondria from oxidative 












Figure 3.5. In gep4Δ cells, LCA alters the composition of several respiratory and non-respiratory protein 
supercomplexes in the inner mitochondrial membrane. Respiratory and non-respiratory protein 
supercomplexes recovered using a first-dimension BN-PAGE were dissociated into individual protein 
components with the help of a second-dimension Tricine-SDS-PAGE and identified using MS-based 
proteomics. Cells of gep4Δ mutant strain were grown in YP medium initially containing 0.2% glucose as 
carbon source in the presence of 50 μM LCA. Cells were collected for the purification of mitochondria at 
day 4. The purification of mitochondria, solubilization of native respiratory and non-respiratory protein 
supercomplexes, their first-dimension BN-PAGE separation, their resolution into individual protein 
components with the help of denaturing Tricine-SDS-PAGE, and the MS-based identification of each of 
these individual protein components were performed as described in Materials and Methods. 
 
 
In gep4Δ mutant cells treated with LCA, the respiratory supercomplex 2: (1) lacks 
ADH3, a mitochondrial alcohol dehydrogenase isozyme III involved in the shuttling of 




integral inner mitochondrial membrane protein with a role in maintaining mitochondrial 
nucleoid structure and number (compare Figures 3.3 and 3.5). In WT cells treated with 
LCA, this respiratory supercomplex is called supercomplex 3 (compare Figures 3.3 and 
3.5). 
 
In gep4Δ mutant cells treated with LCA, the respiratory supercomplex 3 acquires 
respiratory complex III; in WT cells exposed to LCA, this respiratory supercomplex is 
called supercomplex 5 (compare Figures 3.3 and 3.5). 
Importantly, three respiratory and non-respiratory supercomplexes are formed de 
novo in gep4Δ mutant cells treated with LCA; indeed, none of them can be found in WT 
cells exposed to LCA (compare Figures 3.3 and 3.5). A description of these protein 
supercomplexes is provided below. 
In gep4Δ mutant cells treated with LCA, the de novo formed respiratory 
supercomplex 4 includes the following proteins: (1) complex III of the ETC; (2) POR1, a 
voltage-dependent anion channel required for the maintenance of mitochondrial osmotic 
stability and mitochondrial membrane permeability; (3) the ALD4 isoform of 
acetaldehyde dehydrogenase, an enzyme involved in the conversion of acetaldehyde to 
acetyl-CoA in yeast mitochondria; and (4) the IDH1 isoform of isocitrate dehydrogenase, 
an enzyme involved in the TCA cycle (Figure 3.5). 
In gep4Δ mutant cells treated with LCA, the de novo formed non-respiratory 
supercomplex 5 includes the following proteins: (1) KGD1, a component of the 
mitochondrial alpha-ketoglutarate dehydrogenase complex, which catalyzes a key step in 
the TCA cycle, the oxidative decarboxylation of alpha-ketoglutarate to form succinyl- 







required for mitochondrial genome maintenance; (3) the ALD4 isoform of acetaldehyde 
dehydrogenase, an enzyme involved in the conversion of acetaldehyde to acetyl-CoA in 
yeast mitochondria; and (4) fumarase FUM1 that converts fumaric acid to L-malic acid in 
the TCA cycle (Figure 3.5). 
Finally, in gep4Δ mutant cells treated with LCA, the de novo formed non- 
respiratory supercomplex 5 includes the following proteins: (1) citrate synthase CIT1, a 
rate-limiting enzyme of the TCA cycle that catalyzes the condensation of acetyl 
coenzyme A and oxaloacetate to form citrate; (2) aconitase ACO1, which is required for 
the TCA cycle and also independently required for mitochondrial genome maintenance; 
(3) SDH1, a flavoprotein subunit of succinate dehydrogenase that couples the oxidation 
of succinate to the transfer of electrons to ubiquinone as part of the TCA cycle and the 
mitochondrial ETC; (4) dihydrolipoamide dehydrogenase LPD1, a lipoamide 
dehydrogenase component (E3) of the pyruvate dehydrogenase and 2-oxoglutarate 
dehydrogenase multi-enzyme complexes; (5) AAC2, an ADP-ATP carrier protein; (6) 
SSC1, an HSP70 family ATPase that is involved in mitochondrial protein translocation 
and folding; (7) SOD2, a mitochondrial manganese superoxide dismutase that protects 
cells against extremely toxic superoxide radicals; (8) VAS1, a valyl-tRNA synthetase for 
protein synthesis in mitochondria; and (9) alpha-isopropylmalate synthase (2- 
isopropylmalate synthase) LEU4, the main isozyme responsible for the first step in the 
leucine biosynthesis pathway (Figure 3.5). 
In crd1Δ mutant cells not exposed to LCA, the respiratory supercomplex 1: (1) 
lacks respiratory complex II of the ETC; (2) lacks PDA1 (an E1 alpha subunit of the 









Figure 3.6. The composition of respiratory and non-respiratory protein supercomplexes in the inner 
mitochondrial membrane of crd1Δ mutant cells not exposed to LCA. Respiratory and non-respiratory 
protein supercomplexes recovered using a first-dimension BN-PAGE were dissociated into individual 
protein components with the help of a second-dimension Tricine-SDS-PAGE and identified using MS- 
based proteomics. Cells of crd1Δ mutant strain were grown in YP medium initially containing 0.2% 
glucose as carbon source without LCA. Cells were collected for the purification of mitochondria at day 4. 
The purification of mitochondria, solubilization of native respiratory and non-respiratory protein 
supercomplexes, their first-dimension BN-PAGE separation, their resolution into individual protein 
components with the help of denaturing Tricine-SDS-PAGE, and the MS-based identification of each of 
these individual protein components were performed as described in Materials and Methods. 
 
 
of pyruvate to acetyl-CoA) and PDB1 (an E1 alpha subunit of the pyruvate 
dehydrogenase complex, which catalyzes the direct oxidative decarboxylation of 
pyruvate to acetyl-CoA); (3) lacks the mitochondrial external NADH dehydrogenase 





cytosolic NADH to provide cytosolic NADH to the mitochondrial ETC; (4) acquires the 
mitochondrial succinate-fumarate transporter SFC1, which is known to transport 
succinate into and fumarate out of the mitochondrion and to be required for ethanol and 
acetate utilization; and (5) acquires the mitochondrial protein MMF1 (which is required 
for transamination of isoleucine, may regulate specificity of branched-chain 
transaminases Bat1p and Bat2p, and is known to interact genetically with mitochondrial 
ribosomal protein genes) into this supercomplex (compare Figures 3.2 and 3.6). 
In crd1Δ mutant cells not exposed to LCA, the respiratory supercomplex 2 found in 
untreated WT cells (Figure 3.2) is absent (Figure 3.6); this respiratory supercomplex 
consists of respiratory complexes III and V of the ETC, KGD1, POR1, and AAC2. 
In crd1Δ mutant cells not exposed to LCA, the respiratory supercomplex 2 lacks 
respiratory complex III; in untreated WT cells, this respiratory supercomplex is called 
supercomplex 3 (compare Figures 3.2 and 3.6). 
In crd1Δ mutant cells not exposed to LCA, the respiratory supercomplex 4 found in 
untreated WT cells (Figure 3.2) is absent (Figure 3.6); this respiratory supercomplex 
consists of YME2 protein molecules. 
The molecular weight of the respiratory supercomplex 3 found in crd1Δ mutant 
cells not exposed to LCA is significantly higher (Figure 3.6) than that of the 
supercomplex 5 seen in untreated WT cells (Figure 3.2); both these respiratory 
supercomplexes composed of respiratory complexes III, IV and V. 
In crd1Δ mutant cells not exposed to LCA, the respiratory supercomplex 4 lacks 
respiratory complexes III and IV; in untreated WT cells, this respiratory supercomplex is 







In crd1Δ mutant cells not exposed to LCA, the respiratory supercomplex 6 found in 
untreated WT cells (Figure 3.2) is absent (Figure 3.6); this respiratory supercomplex 
consists of respiratory complexes III and V of the ETC, ALD4, IDH1, IDH2, and POR1. 
Importantly, one respiratory and one non-respiratory supercomplexes are formed 
 
de novo in crd1Δ mutant cells not exposed to LCA; indeed, none of them can be found in 
untreated WT cells (compare Figures 3.2 and 3.6). A description of these protein 
supercomplexes is provided below. 
In crd1Δ mutant cells not exposed to LCA, the de novo formed respiratory 
supercomplex 5 includes the following proteins: (1) respiratory complex II of the ETC; 
(2) the IDH2 isoform of isocitrate dehydrogenase, an enzyme involved in the TCA cycle; 
(3) AAC2, an ADP-ATP carrier protein; and (4) CPR3, a mitochondrial peptidyl-prolyl 
cis-trans isomerase (cyclophilin), which catalyzes the cis-trans isomerization of peptide 
bonds N-terminal to proline residues and is involved in protein refolding after import into 
mitochondria (Figure 3.6). 
Finally, in crd1Δ mutant cells not exposed to LCA, the de novo formed respiratory 
supercomplex 6 includes protein molecules of HSP60, a tetradecameric mitochondrial 
chaperonin that not only is required for ATP-dependent folding of precursor polypeptides 
and complex assembly, but also prevents aggregation and mediates protein refolding after 
heat shock (Figure 3.6). 
In crd1Δ mutant cells treated with LCA, the respiratory supercomplex 1: (1) lacks 
respiratory complexes II and IV; (2) lacks the mitochondrial external NADH 
dehydrogenase NDE1, a type II NAD(P)H:quinone oxidoreductase that catalyzes the 









Figure 3.7. In crd1Δ cells, LCA alters the composition of several respiratory and non-respiratory protein 
supercomplexes in the inner mitochondrial membrane. Respiratory and non-respiratory protein 
supercomplexes recovered using a first-dimension BN-PAGE were dissociated into individual protein 
components with the help of a second-dimension Tricine-SDS-PAGE and identified using MS-based 
proteomics. Cells of crd1Δ mutant strain were grown in YP medium initially containing 0.2% glucose as 
carbon source in the presence of 50 μM LCA. Cells were collected for the purification of mitochondria at 
day 4. The purification of mitochondria, solubilization of native respiratory and non-respiratory protein 
supercomplexes, their first-dimension BN-PAGE separation, their resolution into individual protein 
components with the help of denaturing Tricine-SDS-PAGE, and the MS-based identification of each of 
these individual protein components were performed as described in Materials and Methods. 
 
 
lacks the mitochondrial protein MMF1 (which is required for transamination of 
isoleucine, may regulate specificity of branched-chain transaminases Bat1p and Bat2p, 
and is known to interact genetically with mitochondrial ribosomal protein genes) into this 




synthase CIT1, a rate-limiting enzyme of the TCA cycle which catalyzes the condensation 
of acetyl coenzyme A and oxaloacetate to form citrate; (6) acquires aconitase ACO1, 
which is required for the TCA cycle and also independently required for mitochondrial 
genome maintenance; (7) acquires malate dehydrogenase MDH1, an enzyme that 
catalyzes interconversion of malate and oxaloacetate as part of the TCA cycle; (8) 
acquires SDH1, a flavoprotein subunit of succinate dehydrogenase that couples the 
oxidation of succinate to the transfer of electrons to ubiquinone as part of the TCA cycle 
and the mitochondrial ETC; and (9) acquires POR1, a voltage-dependent anion channel 
required for the maintenance of mitochondrial osmotic stability and 
mitochondrial membrane permeability (compare Figures 3.3 and 3.7). 
 
In crd1Δ mutant cells treated with LCA, the respiratory supercomplex 2: (1) lacks 
KGD1, a component of the mitochondrial alpha-ketoglutarate dehydrogenase complex, 
which catalyzes a key step in the TCA cycle, the oxidative decarboxylation of alpha- 
ketoglutarate to form succinyl-CoA; and (2) acquires PHB1, a subunit of the prohibitin 
complex that functions as a membrane chaperone stabilizing newly synthesized proteins 
(compare Figures 3.3 and 3.7). 
The molecular weight of the respiratory supercomplex 3 found in crd1Δ mutant 
cells treated with LCA is significantly higher (Figure 3.7) than that of the supercomplex 5 
seen in WT cells exposed to LCA (Figure 3.3); both these respiratory supercomplexes 
composed of numerous molecules of respiratory complex V. 
In crd1Δ mutant cells treated with LCA, the respiratory supercomplex 4 found in 
WT cells exposed to LCA (Figure 3.3) is absent (Figure 3.7); this respiratory 







In crd1Δ mutant cells treated with LCA, the respiratory supercomplex 4 acquires 
respiratory complex IV; in WT cells exposed to LCA, this respiratory supercomplex is 
called supercomplex 5 (compare Figures 3.2 and 3.6). 
Importantly, one respiratory supercomplex are formed de novo in crd1Δ mutant 
cells treated with LCA; indeed, this supercomplex cannot be found in WT cells exposed 
to LCA (compare Figures 3.3 and 3.7). This respiratory supercomplex includes the 
following proteins: (1) respiratory complexes I, III and V of the ETC; (2) the IDH2 
isoform of isocitrate dehydrogenase, an enzyme involved in the TCA cycle; (3) AAC2, 
an ADP-ATP carrier protein; (4) MDH1, an enzyme that catalyzes interconversion of 
malate and oxaloacetate as part of the TCA cycle; (5) PRX1, a mitochondrial 
peroxiredoxin with thioredoxin peroxidase activity; and (6) MIR1, a mitochondrial 
phosphate carrier that imports inorganic phosphate into mitochondria (Figure 3.7). 
In taz1Δ mutant cells not exposed to LCA, the respiratory supercomplex 1: (1) 
lacks respiratory complex II of the ETC; (2) lacks PDA1 (an E1 alpha subunit of the 
pyruvate dehydrogenase complex, which catalyzes the direct oxidative decarboxylation 
of pyruvate to acetyl-CoA) and PDB1 (an E1 alpha subunit of the pyruvate 
dehydrogenase complex, which catalyzes the direct oxidative decarboxylation of 
pyruvate to acetyl-CoA); (3) lacks AAC2, an ADP-ATP carrier protein; and (4) acquires 
KGD 1, a component of the mitochondrial alpha-ketoglutarate dehydrogenase complex, 
which catalyzes a key step in the TCA cycle, the oxidative decarboxylation of alpha- 
ketoglutarate to form succinyl-CoA (compare Figures 3.2 and 3.8). 
In taz1Δ mutant cells not exposed to LCA, the respiratory supercomplex 2: (1) 
 









Figure 3.8. The composition of respiratory and non-respiratory protein supercomplexes in the inner 
mitochondrial membrane of taz1Δ mutant cells not exposed to LCA. Respiratory and non-respiratory 
protein supercomplexes recovered using a first-dimension BN-PAGE were dissociated into individual 
protein components with the help of a second-dimension Tricine-SDS-PAGE and identified using MS- 
based proteomics. Cells of taz1Δ mutant strain were grown in YP medium initially containing 0.2% glucose 
as carbon source without LCA. Cells were collected for the purification of mitochondria at day 4. The 
purification of mitochondria, solubilization of native respiratory and non-respiratory protein 
supercomplexes, their first-dimension BN-PAGE separation, their resolution into individual protein 
components with the help of denaturing Tricine-SDS-PAGE, and the MS-based identification of each of 
these individual protein components were performed as described in Materials and Methods. 
 
 
channel required for the maintenance of mitochondrial osmotic stability and 
mitochondrial membrane permeability; and (3) lacks KGD1, a component of the 





the TCA cycle, the oxidative decarboxylation of alpha-ketoglutarate to form succinyl- 
CoA (compare Figures 3.2 and 3.8). 
In taz1Δ mutant cells not exposed to LCA, the respiratory supercomplex 3 lacks 
respiratory complex III (compare Figures 3.2 and 3.8). 
In taz1Δ mutant cells not exposed to LCA, the respiratory supercomplex 4 acquires 
respiratory complexes III, IV and V (compare Figures 3.2 and 3.8). 
Of note, instead of a single respiratory supercomplex 5 composed of respiratory 
complexes III, IV and V found in untreated WT cell (Figure 3.2), there are two 
respiratory supercomplexes of very similar molecular weights in taz1Δ mutant cells not 
exposed to LCA (compare Figures 3.2 and 3.8). One of them (which is called the 
respiratory supercomplex 5) consists of respiratory complexes III, IV and V, whereas the 
other supercomplex (which is termed the respiratory supercomplex 6) includes 
respiratory complexes III and V (Figure 3.8). 
Importantly, one respiratory supercomplex is formed de novo in taz1Δ mutant cells 
not exposed to LCA; indeed, this supercomplex cannot be found in untreated WT cells 
(compare Figures 3.2 and 3.8). This respiratory supercomplex 7 includes the following 
proteins: (1) respiratory complex III of the ETC; and (2) the IDH1 and IDH2 isoforms of 
isocitrate dehydrogenase, an enzyme involved in the TCA cycle (Figure 3.8). 
In taz1Δ mutant cells treated with LCA, the respiratory supercomplex 1: (1) lacks 
respiratory complexes II and IV; (2) lacks the mitochondrial protein MMF1 (which is 
required for transamination of isoleucine, may regulate specificity of branched-chain 
transaminases Bat1p and Bat2p, and is known to interact genetically with mitochondrial 









Figure 3.9. In taz1Δ cells, LCA alters the composition of several respiratory and non-respiratory protein 
supercomplexes in the inner mitochondrial membrane. Respiratory and non-respiratory protein 
supercomplexes recovered using a first-dimension BN-PAGE were dissociated into individual protein 
components with the help of a second-dimension Tricine-SDS-PAGE and identified using MS-based 
proteomics. Cells of taz1Δ mutant strain were grown in YP medium initially containing 0.2% glucose as 
carbon source in the presence of 50 μM LCA. Cells were collected for the purification of mitochondria at 
day 4. The purification of mitochondria, solubilization of native respiratory and non-respiratory protein 
supercomplexes, their first-dimension BN-PAGE separation, their resolution into individual protein 
components with the help of denaturing Tricine-SDS-PAGE, and the MS-based identification of each of 
these individual protein components were performed as described in Materials and Methods. 
 
dependent anion channel required for the maintenance of mitochondrial osmotic stability 







In taz1Δ mutant cells treated with LCA, the respiratory supercomplex 2: (1) lacks 
KGD1, a component of the mitochondrial alpha-ketoglutarate dehydrogenase complex, 
which catalyzes a key step in the TCA cycle, the oxidative decarboxylation of alpha- 
ketoglutarate to form succinyl-CoA; (2) acquires MDH1, an enzyme that catalyzes 
interconversion of malate and oxaloacetate as part of the TCA cycle; and (3) acquires 
POR1, a voltage-dependent anion channel required for the maintenance of mitochondrial 
osmotic stability and mitochondrial membrane permeability (compare Figures 3.3 and 
3.9). 
 
In taz1Δ mutant cells treated with LCA, the respiratory supercomplex 3 lacks 
ADH3, a mitochondrial alcohol dehydrogenase isozyme III involved in the shuttling of 
mitochondrial NADH to the cytosol and ethanol production (compare Figures 3.3 and 
3.9). 
 
In taz1Δ mutant cells treated with LCA, the respiratory supercomplex 4: (1) lacks 
respiratory complex V of the ETC; (2) acquires AIM41, a protein required for 
mitochondrial DNA maintenance; and (3) acquires YME2, an integral inner 
mitochondrial membrane protein with a role in maintaining mitochondrial nucleoid 
structure and number (compare Figures 3.3 and 3.9). 
In taz1Δ mutant cells treated with LCA, the respiratory supercomplex 6: (1) lacks 
respiratory complexes III and V of the ETC; (2) lacks the ALD4 isoform of acetaldehyde 
dehydrogenase, an enzyme involved in the conversion of acetaldehyde to acetyl-CoA in 
yeast mitochondria; and (3) lacks POR1, a voltage-dependent anion channel required for 
the maintenance of mitochondrial osmotic stability and mitochondrial membrane 







In taz1Δ mutant cells treated with LCA, the respiratory supercomplex 7: (1) lacks 
POR1, a voltage-dependent anion channel required for the maintenance of mitochondrial 
osmotic stability and mitochondrial membrane permeability; (2) lacks AAC2, an ADP- 
ATP carrier protein; and (3) acquires respiratory complexes II and V of the ETC 
(compare Figures 3.3 and 3.9). 
Importantly, one respiratory supercomplex are formed de novo in taz1Δ mutant 
cells treated with LCA; indeed, this supercomplex cannot be found in WT cells exposed 
to LCA (compare Figures 3.3 and 3.9). This respiratory supercomplex includes the 
following proteins: (1) respiratory complex II of the ETC; (2) MDH1, an enzyme that 
catalyzes interconversion of malate and oxaloacetate as part of the TCA cycle; (3) SSC1, 
an HSP70 family ATPase that is involved in mitochondrial protein translocation and 
folding; (4) CIT1, a rate-limiting enzyme of the TCA cycle which catalyzes the 
condensation of acetyl coenzyme A and oxaloacetate to form citrate; (5) aconitase ACO1, 
which is required for the TCA cycle and also independently required for mitochondrial 
genome maintenance; (6) KGD1, a component of the mitochondrial alpha-ketoglutarate 
dehydrogenase complex, which catalyzes a key step in the TCA cycle, the oxidative 
decarboxylation of alpha-ketoglutarate to form succinyl-CoA; (7) HSP10, a co- 
chaperonin that inhibits the ATPase activity of HSP60, a mitochondrial chaperonin, and 
is involved in protein folding and sorting in the mitochondria; (8) HSP78, a chaperone 
that cooperates with SSC1 in mitochondrial thermotolerance after heat shock ad is also 
known to prevent the aggregation of misfolded proteins and to resolubilize protein 
aggregates; (9) VAS1, a valyl-tRNA synthetase for protein synthesis in mitochondria; 







mitochondrial osmotic stability and mitochondrial membrane permeability; and (11) 
ADH3, a mitochondrial alcohol dehydrogenase isozyme III involved in the shuttling of 






Based on our findings described in Chapter 2 of my thesis and data of other researchers 
working in the field of mitochondrial biology, we hypothesized that, by altering the level 
of CL and other glycerophospholipids within the mitochondrial membrane, LCA could 
modulate the stoichiometry, composition and/or functional state of respiratory 
supercomplexes (respirasomes) in the inner mitochondrial membrane. In our hypothesis, 
such LCA- and CL-dependent remodeling of the mitochondrial respiratory 
supercomplexes (1) may rely on a distinct set of protein components of the respiratory 
complexes that compose the respirasomes; (2) may recruit new mitochondrial protein 
components, not previously known for being permanently associated with the ETC, into 
the remodeled respirasomes; (3) may alter the age-dependent dynamics of mitochondrial 
respiration, oxidative phosphorylation, ADP/ATP exchange, ATP synthesis, membrane 
potential and/or ROS generation; (4) may occur in an age-dependent fashion; and (5) may 
extend longevity by increasing the efficiency of ATP synthesis in chronologically aging 
yeast, altering the age-dependent dynamics of changes in mitochondrially produced ROS 
(thereby protecting yeast from chronic oxidative stress), and/or modulating the longevity- 
defining processes that in mitochondria are governed by proteins newly recruited into the 
remodeled respirasomes (even although some or all of these newly recruited proteins 







To test the validity of this hypothesis, in studies described in this Chapter of my 
thesis we used a multistep method [243 - 253] for recovery of intact respiratory 
complexes and supercomplexes from purified yeast mitochondria, their subsequent first- 
dimension electrophoretic separation using BN-PAGE, their resolution into individual 
protein components with the help of denaturing Tricine-SDS-PAGE, and the MS-based 
identification of each of these individual protein components. 
Findings described in this chapter of my thesis validate our hypothesis. These 
findings revealed several ways of rearranging respiratory supercomplexes in the inner 
mitochondrial membrane of cells exhibiting altered mitochondrial membrane lipidome in 
response to LCA treatment or genetic manipulations impairing the synthesis of CL and 
other glycerophospholipids within the inner membrane of mitochondria. First, by altering 
the level of CL and other glycerophospholipids synthesized and residing in the inner 
mitochondrial membrane, LCA modulates the abundance of several major respiratory 
supercomplexes (respirasomes) in this membrane. Second, LCA- and genetic 
manipulations-driven changes in the inner mitochondrial membrane lipidome cause a 
recruitment of a number of new mitochondrial protein components, not previously known 
for being permanently associated with the ETC, into the remodeled respirasomes. It 
should be emphasized that many of the proteins newly recruited into the remodeled 
respirasomes are known for their essential roles in mitochondria-confined processes that 
define longevity. Specifically, the observed recruitment of AAC2 to the remodelled 
respiratory supercomplexes suggests a mechanism in which the ability of AAC2 to sense 
the rates/efficacies with which electrons are transferred through the ETC and ATP is 







rate of ATP-ADP exchange between mitochondria and cytosol. The resulting increase of 
the efficiency of ATP synthesis in mitochondria of chronologically aging yeast is likely 
to extend their longevity. Furthermore, the observed recruitment of IDH1, IDH2, ALD4 
and HSP60 as well as of ACO1, KGD1, ALD4 and SSC1 to the remodelled respiratory 
supercomplexes is expected to provide an efficient way of coordinating the rates of 
NADH and acetyl-CoA synthesis with functional states of numerous proteins governed 
by the chaperone and protein import activities of HSP60 and SSC1 in mitochondria, 
thereby extending yeast longevity. Moreover, the observed recruitment of VAS1 (a valyl- 
tRNA synthetase for mitochondrial protein synthesis) to the remodelled respiratory 
supercomplexes is expected to provide an efficient way of coordinating the rates of 
electron transher through the ETC, ATP generation and NADH synthesis with the 
synthesis of mitochondrial DNA-encoded proteins. Again, this remodeling of respiratory 






Findings described here imply that, by altering the level of CL and other 
glycerophospholipids within the mitochondrial membrane, LCA modulates the 
abundance and composition of respiratory supercomplexes (respirasomes) in the inner 
mitochondrial membrane. These findings revealed several ways of rearranging 
respiratory supercomplexes in the inner mitochondrial membrane of cells exhibiting 
altered mitochondrial membrane lipidome in response to LCA treatment or genetic 
manipulations impairing the synthesis of CL and other glycerophospholipids within the 







rearrangement are likely to delay yeast aging by beneficially influencing mitochondria- 
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